Amedeo Smart

Free Medical Literature Service

 

Amedeo

Vaccines
  Free Subscription

Articles published in
PLoS One
    January 2026
  1. AZIZ K, Ismail MS, Bibars M, Selim N, et al
    Attitude, self-efficacy, and perceived risk toward seasonal influenza vaccination among primary care physicians in Qatar: A cross-sectional study.
    PLoS One. 2026;21:e0323518.
    >> Share

  2. ABDELHAMED H, Riman MM, Arick MA 2nd, Dawood AS, et al
    Investigation mechanisms of action and resistance of Edwardsiella ictaluri to trans-cinnamaldehyde.
    PLoS One. 2026;21:e0340053.
    >> Share

  3. ZENG Z, Sathasivam S, Xin J, Zhao H, et al
    Public participation in healthcare safety: A tripartite evolutionary game model with evidence from diverse international cases.
    PLoS One. 2026;21:e0339304.
    >> Share

  4. CUI L, Tong N, Hou S, Yu C, et al
    Adverse events following Synflorix vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 2010-2024.
    PLoS One. 2026;21:e0338640.
    >> Share

  5. SULIS G, Maredia N, Wolfson C, Basta NE, et al
    Changes in pneumococcal vaccine coverage in the Canadian Longitudinal Study on Aging (CLSA): An analysis based on the 2018-2021 follow-up 2 survey.
    PLoS One. 2026;21:e0338213.
    >> Share

  6. HOU Y, Chen H, Jiang Y, Huang H, et al
    Shifting epidemiological patterns and strain replacement of hand, foot, and mouth disease in southern China, 2009-2022: A longitudinal study.
    PLoS One. 2026;21:e0341302.
    >> Share


  7. Correction: Design of a multi-epitope recombinant BCG vaccine targeting Brucella OMP31, LptE and VirB2 in immunoinformatics approaches.
    PLoS One. 2026;21:e0342000.
    >> Share

  8. DUARTE CM, Basile LA, Noseda DG, Fasolo P, et al
    Developing a simple, cost-effective proof-of-concept vaccine candidate against EHEC for cattle.
    PLoS One. 2026;21:e0341075.
    >> Share

  9. AGYARE G, Courtin D, Asamoah Sakyi S, Nakotey GK, et al
    Malaria-diabetes comorbidity is linked to higher parasitaemia and enhanced IgG response to malaria vaccine candidate antigens.
    PLoS One. 2026;21:e0341659.
    >> Share

  10. EDAE CK, Bedada AT, Teklemariam MD, Tolesa MB, et al
    A prospective evaluation of Johnson & Johnson COVID-19 vaccine on glycemic biomarkers in type 2 diabetes mellitus in Ethiopia.
    PLoS One. 2026;21:e0340457.
    >> Share

  11. DINERO RE, Monti WB, Kmush BL
    Regional political climate's moderating role in the association between political conservatism and COVID-19 vaccine hesitancy in the United States.
    PLoS One. 2026;21:e0342063.
    >> Share

  12. KIM S, Kim K
    Combined association of socioeconomic status and type 2 diabetes with influenza vaccination in older adults: A cross-sectional analysis of the Korea National Health and Examination Survey (2019-2022).
    PLoS One. 2026;21:e0341831.
    >> Share

  13. ARKOK HS, Wahyono TYM, Aldila D, Prihartono NA, et al
    Modeling HBV transmission dynamics in Indonesia (2024-2030) using a SIVRM model: Evaluating optimal control strategies for elimination by 2030.
    PLoS One. 2026;21:e0341120.
    >> Share

  14. MOI F, Nguyen VM, Archer R, Namalela T, et al
    The cost and cost drivers of delivering COVID-19 vaccines in low- and middle-income countries: a bottom-up costing study of rollouts in seven countries.
    PLoS One. 2026;21:e0341964.
    >> Share

  15. MA H, Tatum FM, Briggs RE, Dassanayake RP, et al
    Transcriptome profiling indicates varied gene responses to Pasteurella multocida mutant infections in cattle.
    PLoS One. 2026;21:e0341813.
    >> Share

  16. AHMAD S, Aslam S, Khalid A
    Multi-epitope vaccine design against Monkeypox virus: An immunoinformatics approach.
    PLoS One. 2026;21:e0342087.
    >> Share

  17. HAILE AW, Kebede EB, Bagilkar V, Mamo TW, et al
    Uptake of measles second dose vaccine among children aged 15-35 months at Mettu Woreda, Illu Aba Bor Zone, Ethiopia: A community-based cross-sectional study.
    PLoS One. 2026;21:e0342931.
    >> Share

  18. SANJO-ODUTAYO A, Oyibo P, Eyawo O
    Parental perspectives on human papillomavirus (HPV) vaccination of school-aged girls in Ilishan, Nigeria: A qualitative study protocol.
    PLoS One. 2026;21:e0341563.
    >> Share

  19. VOLKMAN HR, de Munter L, Nguyen JL, Tran TMP, et al
    Durability of the BNT162b2 XBB:1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platform.
    PLoS One. 2026;21:e0342382.
    >> Share

  20. HASMUKHARAY K, Verma AK, Aravindhan K, Alagappan PRS, et al
    Prospective Evaluation of Antibody Response post COVID-19 vaccination in older persons >== 60 years old (PEARL 60): A longitudinal 15-months study in a tertiary centre in Malaysia.
    PLoS One. 2026;21:e0340891.
    >> Share

  21. KO Y, Seo Y, Park JJ, Kim EJ, et al
    Smallpox outbreak scenarios and reactive intervention protocols: A mathematical model-based analysis applied to the Republic of Korea.
    PLoS One. 2026;21:e0315072.
    >> Share

  22. CHEN F, Nakanishi H, Sekizawa Y, Ochi S, et al
    Correction: Investigating the causal effects of COVID-19 vaccination on the adoption of protective behaviors in Japan: Insights from a fuzzy regression discontinuity design.
    PLoS One. 2026;21:e0342590.
    >> Share

  23. THAKUR A, Meza-Torres B, Fan X, Byford R, et al
    Prediction of COVID-19 hospitalisation, ICU admission or death following ChAdOx1 vaccination using artificial intelligence: A clinical predictive model from the English RAVEN study.
    PLoS One. 2026;21:e0336449.
    >> Share

  24. HADDADI M, Golestani A, Farzi Y, Rezaei N, et al
    Iran is falling behind WHO cervical cancer elimination targets: HPV vaccination coverage and cervical cancer screening participation in 2021.
    PLoS One. 2026;21:e0341888.
    >> Share

  25. ZHANG X, Thomas MH, Lynch A, Shi H, et al
    Assessment of immunogenicity and protection induced by COBRA HA vaccines formulated with Infectimune in young and elderly ferrets.
    PLoS One. 2026;21:e0339613.
    >> Share

  26. THAKKAR N, Oteri AJ, McCarthy KA
    Routine immunization intensification, vaccination campaigns, and measles transmission in Southern Nigeria.
    PLoS One. 2026;21:e0341016.
    >> Share

  27. NOREEN K, Khalid SN, Noor M, Maryam S, et al
    Cultural adaptation and content validation of the WHO BeSD framework for HPV vaccination in Pakistan: A two-phase Delphi and cognitive interview study.
    PLoS One. 2026;21:e0335358.
    >> Share

  28. SULIS G, Maredia N, Wolfson C, Basta NE, et al
    Correction: Changes in pneumococcal vaccine coverage in the Canadian Longitudinal Study on Aging (CLSA): An analysis based on the 2018-2021 follow-up 2 survey.
    PLoS One. 2026;21:e0343252.
    >> Share

  29. RATREE S, Assavapokee N, Santibenchakul S, Sirisabya N, et al
    Reported adverse events following COVID-19 vaccination in gynecologic cancer patients in Thailand: A descriptive study.
    PLoS One. 2026;21:e0342303.
    >> Share

  30. KHAN A, Ahmad A, Badshah F, Ali M, et al
    Immunoinformatics-driven design of multi-epitope vaccine targeting antibiotic-resistant Salmonella typhimurium.
    PLoS One. 2026;21:e0342426.
    >> Share

  31. SYABBALO E, Mpisa S, Vinikoor MJ, Wamundila M, et al
    Hepatitis B immunity and vaccine completion among adults at increased risk for hepatitis B infection in Zambia.
    PLoS One. 2026;21:e0339690.
    >> Share

  32. RAHIMNAHAL S, Yousefizadeh S, Mohammadi Y
    Designing a novel vaccine against COVID-19 based on spike SARS-Cov-2 notable mutations using immunoinformatics approaches.
    PLoS One. 2026;21:e0334662.
    >> Share

  33. MOLTOT T, Gebreegziabher ZA, Walle AD, Nigussie M, et al
    Second-dose measles vaccination coverage and associated factors among children aged 19 to 35 months in Debre Birhan city, Ethiopia, 2024: A community-based cross-sectional study.
    PLoS One. 2026;21:e0342501.
    >> Share

  34. MAHDEEN AA, Hossain I, Masum MHU, Rabbi TMF, et al
    A novel mRNA-based multiepitope vaccine candidate against Cryptosporidium hominis and Cryptosporidium parvum employing reverse-vaccinology and immunoinformatics approaches.
    PLoS One. 2026;21:e0343643.
    >> Share

    January 2025
  35. WANG D, Chen S, Cui G, Wang D, et al
    The survey of vaccination hesitancy among the residents in Jinan.
    PLoS One. 2025;20:e0309431.
    >> Share

  36. ABDEL-QADER DH, Abdel-Qader H, Silverthorne J, Kongkaew C, et al
    Investigating the point prevalence, types, severity, causes and predictors of vaccines administration errors during COVID-19 pandemic in Jordan.
    PLoS One. 2025;20:e0312050.
    >> Share

  37. METELMANN S, Thompson A, Donten A, Oke S, et al
    A systematic review to identify research gaps in studies modeling MenB vaccinations against Neisseria infections.
    PLoS One. 2025;20:e0316184.
    >> Share

  38. IGOMU EE, Mamman PH, Adamu J, Muhammad M, et al
    Immunoinformatics design of a novel multiepitope vaccine candidate against non-typhoidal salmonellosis caused by Salmonella Kentucky using outer membrane proteins A, C, and F.
    PLoS One. 2025;20:e0306200.
    >> Share

  39. BANTIE GM, Tadege M, Nigussie TZ, Woya AA, et al
    Regional disparities of full pentavalent vaccine uptake and the determinants in Ethiopia: Mapping and spatial analysis using the EDHS data.
    PLoS One. 2025;20:e0312514.
    >> Share

  40. EVEREST L, Henderson J, Ma C, Prebeg M, et al
    Relationship between mental health and substance abuse on COVID-19 vaccine hesitancy in youth: A mixed methods longitudinal cohort study.
    PLoS One. 2025;20:e0313157.
    >> Share

  41. TAKAHASHI Y, Sasamori Y, Higuchi R, Kaku A, et al
    Effects of different educational interventions on cervical cancer knowledge and human papillomavirus vaccination uptake among young women in Japan: Preliminary results of a cluster randomized controlled trial.
    PLoS One. 2025;20:e0311588.
    >> Share

  42. HERGOTT M, Andreski M, Rovers J
    Vaccine hesitancy among health paraprofessionals: A mixed methods study.
    PLoS One. 2025;20:e0312708.
    >> Share

  43. PHILLIPS G, Racine E, Naughton AM, Lane J, et al
    Understanding uptake of the COVID-19 vaccination among the homeless: A mixed methods evaluation.
    PLoS One. 2025;20:e0312617.
    >> Share

  44. RAMAKRISHNAN U, Aggarwal T, Kondabagil K
    Sequence and biochemical analysis of vaccinia virus A32 protein: Implications for in vitro stability and coiled-coil motif mediated regulation of the DNA-dependent ATPase activity.
    PLoS One. 2025;20:e0316818.
    >> Share

  45. RAHMAN MM, Masum MHU, Parvin R, Das SC, et al
    Designing of an mRNA vaccine against high-risk human papillomavirus targeting the E6 and E7 oncoproteins exploiting immunoinformatics and dynamic simulation.
    PLoS One. 2025;20:e0313559.
    >> Share

  46. MOHAMMAD KM, Akhi AA, Kamrujjaman M
    Bifurcation analysis of an influenza A (H1N1) model with treatment and vaccination.
    PLoS One. 2025;20:e0315280.
    >> Share

  47. NAHIAN M, Shahab M, Khan MR, Akash S, et al
    Development of a broad-spectrum epitope-based vaccine against Streptococcus pneumoniae.
    PLoS One. 2025;20:e0317216.
    >> Share

  48. BRUGNOLI E, Delmastro M
    Dynamics and triggers of misinformation on vaccines.
    PLoS One. 2025;20:e0316258.
    >> Share

  49. YU F, Younas Khan M, Bilal Riaz M, Ullah S, et al
    Assessing the global dynamics of Nipah infection under vaccination and treatment: A novel computational modeling approach.
    PLoS One. 2025;20:e0309360.
    >> Share

  50. AGUILAR-PALMA SK, McCoy TP, Mann-Jackson L, Alonzo J, et al
    Characteristics influencing COVID-19 testing and vaccination among Spanish-speaking Latine persons in North Carolina.
    PLoS One. 2025;20:e0317794.
    >> Share

  51. ARGHAL R, Rubin H, Saeedi Bidokhti S, Sarkar S, et al
    Protect or prevent? A practicable framework for the dilemmas of COVID-19 vaccine prioritization.
    PLoS One. 2025;20:e0316294.
    >> Share

  52. DRUSZCZYNSKA M, Seweryn M, Wawrocki S, Pankowska A, et al
    Interferon (IFN)-gamma (gamma) inducible protein 10 (IP-10) in the diagnosis of latent and active tuberculosis in Bacille Calmette Guerin (BCG)-vaccinated pediatric population.
    PLoS One. 2025;20:e0314400.
    >> Share

  53. RAZAI MS, Ussher M, Goldsmith L, Hargreaves S, et al
    Navigating vaccination in pregnancy: Qualitative study in 21 ethnically diverse pregnant women.
    PLoS One. 2025;20:e0310823.
    >> Share

  54. MUTHIRU AW, Muema J, Mutono N, Thumbi SM, et al
    Beyond the jab: Unravelling the complexities of vaccine adoption for East Coast Fever in rural Kenya.
    PLoS One. 2025;20:e0315906.
    >> Share

  55. MULUGETA KT, Dawed MY, Teklu SW
    Impact of media coverage on the transmission dynamics of TB with vaccines and treatment.
    PLoS One. 2025;20:e0314324.
    >> Share

  56. HEGAZI MA, Sayed MH, Butt NS, Alahmadi TS, et al
    Navigating the shots: Parental willingness to immunize their children with COVID-19 vaccines in Saudi Arabia explored through a systematic review and meta-analysis.
    PLoS One. 2025;20:e0317983.
    >> Share

  57. SOLANKI G, Cleary S, Little F
    Impact of COVID-19 vaccination on hospitalization, hospital utilization and expenditure for COVID-19: A retrospective cohort analysis of a South African private health insured population.
    PLoS One. 2025;20:e0317686.
    >> Share

  58. HAMISI MA, Asri NAM, Yassim ASM, Suppian R, et al
    A systematic review on malaria and Tuberculosis (TB) vaccine challenges in sub-Saharan African clinical trials.
    PLoS One. 2025;20:e0317233.
    >> Share

  59. SIDDIKI AZ, Alam S, Fuad Bin Hossen F, Alim MA, et al
    Development of a multi-epitope chimeric vaccine in silico against Babesia bovis, Theileria annulata, and Anaplasma marginale using computational biology tools and reverse vaccinology approach.
    PLoS One. 2025;20:e0312262.
    >> Share

  60. ZUBAIR S, Parvaiz F, Abualait T, Al-Regaiey K, et al
    Computational design of multi-epitope vaccine against Hepatitis C Virus infection using immunoinformatics techniques.
    PLoS One. 2025;20:e0317520.
    >> Share

  61. NAHIAN M, Khan MR, Rahman F, Reza HM, et al
    Immunoinformatic strategy for developing multi-epitope subunit vaccine against Helicobacter pylori.
    PLoS One. 2025;20:e0318750.
    >> Share

  62. NAZ H, Timotheous R, Sarwar MF, Nadeem T, et al
    Utilizing the subtractive proteomics approach to design ensemble vaccine against Candida lusitaniae for immune response stimulation; a bioinformatics study.
    PLoS One. 2025;20:e0316264.
    >> Share

  63. OTENG AGYEMAN F, Ma Z, Li M, Kwasi Sampene A, et al
    Correction: Relevance of COVID-19 vaccine on the tourism industry: Evidence from China.
    PLoS One. 2025;20:e0319203.
    >> Share

  64. GANESHAN H, Huang J, Belmonte M, Belmonte A, et al
    Human responses to the DNA prime/chimpanzee adenovirus (ChAd63) boost vaccine identify CSP, AMA1 and TRAP MHC Class I-restricted epitopes.
    PLoS One. 2025;20:e0318098.
    >> Share

  65. GELYI EK, Azaare J, Bonso NK, Kpordoxah MR, et al
    Impact of perceived factors of coronavirus infection on COVID-19 vaccine uptake among healthcare workers in Ghana-Evidence from a cross-sectional analysis.
    PLoS One. 2025;20:e0318662.
    >> Share

  66. KOSTINOV M, Chuchalin A, Chebykina A, Khrapunova I, et al
    Clinical status and cytokine profiles in patients with asthma or chronic obstructive pulmonary disease vaccinated against influenza.
    PLoS One. 2025;20:e0313539.
    >> Share

  67. PARVIN R, Masum MHU, Heema HP, Akter A, et al
    Designing of a multiepitope-based vaccine against echinococcosis utilizing the potent Ag5 antigen: Immunoinformatics and simulation approaches.
    PLoS One. 2025;20:e0310510.
    >> Share

  68. SCHMIDHUBER S, Dickie J, Cserepes M, Tovari J, et al
    WISIT vaccines based on IL-31-derived peptides as a novel therapeutic approach for chronic pruritic dermatoses.
    PLoS One. 2025;20:e0318293.
    >> Share

  69. CONTRERAS M, Rafael M, Sobrino I, Almazan C, et al
    Modelling protein-protein interactions for the design of vaccine chimeric antigens with protective epitopes.
    PLoS One. 2025;20:e0318439.
    >> Share

  70. TROGDON JG, Khanderia A, Brignole K, Lewis JA, et al
    Gains vs losses in pay-for-performance: Stated preference evidence from a U.S. survey.
    PLoS One. 2025;20:e0318704.
    >> Share

  71. MAMELI C, Valsecchi C, Cereda D, Scarioni S, et al
    Type 1 diabetes incidence during COVID-19 pandemic has not been influenced by COVID-19 vaccination in northern Italy region, Lombardy.
    PLoS One. 2025;20:e0316340.
    >> Share

  72. SODHI S, Chamali R, Praveen D, Sharma M, et al
    Does integration matter? an international cross-sectional study on the relationship between perceived public health and primary care integration and COVID-19 vaccination rates.
    PLoS One. 2025;20:e0317970.
    >> Share

  73. SHI H, Zhang X, Ross TM
    A single dose of inactivated influenza virus vaccine expressing COBRA hemagglutinin elicits broadly-reactive and long-lasting protection.
    PLoS One. 2025;20:e0308680.
    >> Share


  74. Correction: Determinants of the COVID-19 vaccine hesitancy spectrum.
    PLoS One. 2025;20:e0315702.
    >> Share

  75. MISHRA SK, Senathilake KS, Kumar N, Patel CN, et al
    Exploratory algorithms to devise multi-epitope subunit vaccine by examining HIV-1 envelope glycoprotein: An immunoinformatics and viroinformatics approach.
    PLoS One. 2025;20:e0318523.
    >> Share

  76. MOTAMEDI H, Shoja S, Abbasi M
    Immunoinformatic evaluation for the development of a potent multi-epitope vaccine against bacterial vaginosis caused by Gardnerella vaginalis.
    PLoS One. 2025;20:e0316699.
    >> Share

  77. MACHADO-VIEIRA R, Krause TM, Jones G, Teixeira AL, et al
    Protective effects of psychiatric medications against COVID-19 mortality before vaccines.
    PLoS One. 2025;20:e0310438.
    >> Share

  78. KHATOONI Z, Broderick G, Anand SK, Wilson HL, et al
    Combined immunoinformatic approaches with computational biochemistry for development of subunit-based vaccine against Lawsonia intracellularis.
    PLoS One. 2025;20:e0314254.
    >> Share

  79. OKITA G, Suenaga K, Sakaguchi M, Murakami T, et al
    A novel oncolytic vaccinia virus with multiple gene modifications involved in viral replication and maturation increases safety for intravenous administration while maintaining proliferative potential in cancer cells.
    PLoS One. 2025;20:e0312205.
    >> Share

  80. ADAMU H, Lawal S, Bawa IA, Sani AM, et al
    Prevalence and pattern of adverse events following COVID-19 vaccination among adult population in Sokoto metropolis, northwest, Nigeria.
    PLoS One. 2025;20:e0277585.
    >> Share

  81. HTET H, Wichaidit W, Chuaychai A, Sottiyotin T, et al
    Perspectives of stakeholders on barriers to COVID-19 protective behaviors adherence and vaccination among Myanmar migrant workers in southern Thailand: A qualitative study.
    PLoS One. 2025;20:e0317714.
    >> Share

  82. ASIIMWE S, Bagenda FN, Mugisa T
    Factors associated with uptake of human papilloma virus vaccine among adolescent girls: A cross sectional survey on insights into HPV Infection Prevention in Kabarole District, Western Uganda.
    PLoS One. 2025;20:e0306960.
    >> Share

  83. BEIG M, Sholeh M, Moradkasani S, Shahbazi B, et al
    Development of a multi-epitope vaccine against Acinetobacter baumannii: A comprehensive approach to combating antimicrobial resistance.
    PLoS One. 2025;20:e0319191.
    >> Share

  84. SHEN J, Ji C, Luo X, Hu Y, et al
    Correction: Economic evaluation on meningococcal vaccination strategies among children under nine years of age in Zhejiang province, China.
    PLoS One. 2025;20:e0320386.
    >> Share

  85. ZUBAIR A, Al-Emam A, Ali M, Hussain SM, et al
    Targeting HIV-1 conserved regions: An immunoinformatic pathway to vaccine innovation for the Asia.
    PLoS One. 2025;20:e0317382.
    >> Share

  86. SAHA S, Millier M, Samaranayaka A, Edmonds L, et al
    Immunogenicity and safety of measles-mumps-rubella vaccine delivered by the aerosol, intradermal and intramuscular routes in previously vaccinated young adults: a randomized controlled trial protocol.
    PLoS One. 2025;20:e0318893.
    >> Share

  87. BAAKLINY M, Ghosn N, Saleh N, Maison P, et al
    Effectiveness of the Pfizer-BioNTech (BNT162b2) vaccine against the omicron variant of SARS-CoV-2 among adults aged 50 and above: A case-control study in Lebanon, June 2022.
    PLoS One. 2025;20:e0318344.
    >> Share

  88. ALAHMADI S, Hoyle R, Head M, Brede M, et al
    Modelling the mitigation of anti-vaccine opinion propagation to suppress epidemic spread: A computational approach.
    PLoS One. 2025;20:e0318544.
    >> Share

  89. ANTEHUNEGN TESEMA G, Sarfo M, Okeke SR, Ameyaw EK, et al
    Unveiling the Drivers of Polio Vaccine Uptake: Insights from a Multi-Country Study of 37 Nations in Sub-Saharan Africa.
    PLoS One. 2025;20:e0316884.
    >> Share

  90. TAYLOR-ABDULAI HB, Dzantor EK, Mensah NK, Asumah MN, et al
    Coronavirus disease 2019 (COVID-19) vaccine acceptability in Ghana: An urban-based population study.
    PLoS One. 2025;20:e0319798.
    >> Share

  91. LARA-RAMIREZ D, Santacruz-Tinoco CE, Ramon-Gallegos E, Munoz-Medina JE, et al
    In silico design of Ebola virus Glycoprotein antigenic peptides as vaccine candidates.
    PLoS One. 2025;20:e0319496.
    >> Share

  92. OKAFUJI I, Washio R, Okafuji T, Tanaka Y, et al
    Use of a cooling pack to reduce subcutaneous vaccine injection pain in children aged 3-6 years: A single-blind, randomized, parallel-group multicenter study.
    PLoS One. 2025;20:e0318322.
    >> Share

  93. SADONES O, Kramarska E, Sainz-Mejias M, Berisio R, et al
    Identification of cross-reactive vaccine antigen candidates in Gram-positive ESKAPE pathogens through subtractive proteome analysis using opsonic sera.
    PLoS One. 2025;20:e0319933.
    >> Share

  94. LAMICHHANE R, Pathak ID, Pathak BD, Adhikari P, et al
    Low Hepatitis B vaccination rates among medical students in South Asia: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0320330.
    >> Share

  95. BURKE-GARCIA A, Cutroneo E, Afanaseva D, Madden K, et al
    Findings from a qualitative analysis: Social media influencers of color as trusted messengers of HPV vaccination messages.
    PLoS One. 2025;20:e0319160.
    >> Share


  96. Retraction: An immunoinformatics and extensive molecular dynamics study to develop a polyvalent multi-epitope vaccine against cryptococcosis.
    PLoS One. 2025;20:e0322316.
    >> Share

  97. MALIK TM, Bakker KM, Oidtman RJ, Sharomi O, et al
    A dynamic transmission model for assessing the impact of pneumococcal vaccination in the United States.
    PLoS One. 2025;20:e0305892.
    >> Share

  98. CARMOLA LR, Roebling AD, Khosravi D, Langsjoen RM, et al
    Viral and host factors associated with SARS-CoV-2 disease severity in Georgia, USA.
    PLoS One. 2025;20:e0317972.
    >> Share

  99. VO LT, Phan DQ, Tran HG, Nguyen LTP, et al
    Hepatitis B vaccine coverage in health care students: a cross-sectional study in Vietnam.
    PLoS One. 2025;20:e0320860.
    >> Share

  100. DE BRITO KC, da Silva MFCR, Cardoso CW, Silva LK, et al
    A randomized, controlled trial of a web-based tailored intervention to increase human papillomavirus vaccination among people living with HIV/AIDS.
    PLoS One. 2025;20:e0319646.
    >> Share

  101. XIE M, Younas Khan M, Ullah S, Farooq M, et al
    Optimal control analysis for the transmission of Nipah infection with imperfect vaccination.
    PLoS One. 2025;20:e0317408.
    >> Share

  102. OROTTA M, Munseri P, Massawe RV, Orotta GM, et al
    Hepatitis B virus: Prevalence, vaccination coverage and immune responses to immunization among healthcare workers at Muhimbili National Hospital.
    PLoS One. 2025;20:e0321623.
    >> Share

  103. VILLOTA SD, Veloz-Villavicencio E, Garcia-Iturralde S, Arevalo JV, et al
    Validation of new equipment for SARS-CoV-2 diagnosis in Ecuador: Detection of the virus and antibodies generated by disease and vaccines with one POC device.
    PLoS One. 2025;20:e0321794.
    >> Share

  104. IWU CD, Shrestha P, Littman AJ, Hood JE, et al
    The association between healthcare access and shingles vaccination among older adults in Virginia, United States.
    PLoS One. 2025;20:e0316429.
    >> Share

  105. MURPHY R, Pomerantz L, Kuruppumullage Don P, Sung Kim J, et al
    Correction: Age and political leaning predict COVID-19 vaccination status at a large, multi-campus, public university in Pennsylvania: A cross-sectional survey.
    PLoS One. 2025;20:e0322942.
    >> Share


  106. Retraction: Immunoinformatic strategy for developing multi-epitope subunit vaccine against Helicobacter pylori.
    PLoS One. 2025;20:e0323864.
    >> Share


  107. Retraction: Designing of an mRNA vaccine against high-risk human papillomavirus targeting the E6 and E7 oncoproteins exploiting immunoinformatics and dynamic simulation.
    PLoS One. 2025;20:e0323771.
    >> Share

  108. HIRANBURANA N, Thippamom N, Avihingsanon A, Wacharapluesadee S, et al
    Differential immunogenicity in people living with HIV with varying CD4 levels after bivalent mRNA COVID-19 booster vaccination.
    PLoS One. 2025;20:e0317940.
    >> Share

  109. YU H, Bonett S, Oyiborhoro U, Aryal S, et al
    Correction: Psychosocial correlates of parents' willingness to vaccinate their children against COVID-19.
    PLoS One. 2025;20:e0323661.
    >> Share

  110. RAPAJIC-MORAN I, Filipic B, Rajkovic D, Rakic M, et al
    Strengthening the role of community pharmacy in HPV vaccination roll-out in Serbia at national and local levels: A pharmacy-based education approach.
    PLoS One. 2025;20:e0322584.
    >> Share

  111. VANOUDENHOVE J, Liu Y, Nelakanti R, Kim D, et al
    Impact of memory T cells on SARS-CoV-2 vaccine response in hematopoietic stem cell transplant.
    PLoS One. 2025;20:e0320744.
    >> Share

  112. EZEZIKA O, Pellitier Z, Muhimpundu S, Daboud C, et al
    Exploring vaccination attitudes in African communities in Canada: A mixed-methods study protocol.
    PLoS One. 2025;20:e0319584.
    >> Share

  113. MATHKOUR A, Alzahrani AH, Narapureddy BR, Alqahtani FM, et al
    Prevalence and risk factors of burnout among employees at COVID-19 vaccination centers: A cross-sectional study.
    PLoS One. 2025;20:e0322803.
    >> Share


  114. Retraction: In Silico design of a multi-epitope vaccine for Human Parechovirus: Integrating immunoinformatics and computational techniques.
    PLoS One. 2025;20:e0324093.
    >> Share

  115. DE LA CRUZ HERRERA M, Fuster-Casanovas A, Miro Catalina Q, Cigarrran Mensa M, et al
    Use of virtual reality in the reduction of pain after the administration of vaccines among children in primary care centers in Central Catalonia: Randomized clinical trial.
    PLoS One. 2025;20:e0322840.
    >> Share

  116. METKIE KA, Asgedom YS, Sertsewold SG, Abebe M, et al
    Polio vaccination and marginal effects among children aged 12-23 months in Lesotho using 2024 LDHS data: A multilevel analysis approach.
    PLoS One. 2025;20:e0322731.
    >> Share

  117. LAYTON JB, Lloyd PC, Peetluk LS, Jiao Y, et al
    Effectiveness over time of a primary series of the original monovalent COVID-19 vaccines in adults in the United States.
    PLoS One. 2025;20:e0320434.
    >> Share


  118. Retraction: Exploratory algorithms to devise multi-epitope subunit vaccine by examining HIV-1 envelope glycoprotein: An immunoinformatics and viroinformatics approach.
    PLoS One. 2025;20:e0324076.
    >> Share


  119. Retraction: An immunoinformatics and extended molecular dynamics approach for designing a polyvalent vaccine against multiple strains of Human T-lymphotropic virus (HTLV).
    PLoS One. 2025;20:e0324071.
    >> Share

  120. SIM J, Smith LE, Amlot R, Rubin GJ, et al
    Discrimination of a single-item scale to measure intention to have a COVID-19 vaccine.
    PLoS One. 2025;20:e0322503.
    >> Share

  121. MANTINA NM, Smith J, Miiro FN, Magrath PA, et al
    Perspectives of HPV vaccine decision-making among young adults: A qualitative systematic review and evidence synthesis.
    PLoS One. 2025;20:e0321448.
    >> Share

  122. LI Y, Zhao IY, Lu W, Leung SF, et al
    Are people willing to take regular vaccinations? A qualitative study among diverse ethnic groups in Hong Kong.
    PLoS One. 2025;20:e0318631.
    >> Share

  123. KIM SH, Jung M
    Disentangling behavioral determinants of seasonal influenza vaccination in post-corona era: An integrated model approach.
    PLoS One. 2025;20:e0323184.
    >> Share

  124. NASIR M, Weeks WB, Gholami S, Marfin A, et al
    Modeling protective meningococcal antibody responses and factors influencing antibody persistence following vaccination with MenAfriVac using machine learning.
    PLoS One. 2025;20:e0323384.
    >> Share

  125. SHIN E, Yun JS, Lee YR, Cha HR, et al
    Efficacy and immunogenicity of rKVAC85B in a BCG prime-boost regimen against H37Rv and HN878 Mycobacterium tuberculosis strains.
    PLoS One. 2025;20:e0322147.
    >> Share

  126. XIA Z, Meng J, Wang X, Liu P, et al
    Efficacy of BCG vaccination against COVID-19 in health care workers and non-health care workers: A meta-analysis of randomized controlled trials.
    PLoS One. 2025;20:e0321511.
    >> Share

  127. LANG HP, Almeer FF, Jenkins MK, Friedenberg SG, et al
    Rabies vaccination induces a CD4+ TEM and CD4+CD8+ TEMRA TH1 phenotype in dogs.
    PLoS One. 2025;20:e0323823.
    >> Share

  128. OYEDEJI O, North C, Kintziger KW, Ehrlich S, et al
    Understanding young adults' perceptions regarding human papillomavirus vaccination: A qualitative study.
    PLoS One. 2025;20:e0323063.
    >> Share

  129. ELKARHAT Z, Tifrouin I, Bamouh Z, Tadlaoui KO, et al
    First identification of ORF virus causing contagious ecthyma in Morocco (MOR20): Genomic, phylogenetic, and sequence variants analyses for vaccine design.
    PLoS One. 2025;20:e0323383.
    >> Share

  130. BELICHENKO PV, Madani R, Rey-Bellet L, Pihlgren M, et al
    Correction: An Anti-beta-Amyloid vaccine for treating cognitive deficits in a mouse model of down syndrome.
    PLoS One. 2025;20:e0324280.
    >> Share

  131. SOARES P, Gomez V, Gaio V, Santos JA, et al
    A protocol for high-dose quadrivalent influenza vaccine effectiveness in the community and long-term care facilities using electronic health records.
    PLoS One. 2025;20:e0314177.
    >> Share

  132. NOREEN K, Khalid SN, Javaid M, Khan SA, et al
    Public Health Implications of Introducing Human Papillomavirus (HPV) Vaccination in Pakistan: A protocol for a mixed-method study to explore community perceptions and health system preparedness.
    PLoS One. 2025;20:e0323826.
    >> Share

  133. AJIT J, Chen Q, Ung T, Rosenberger M, et al
    beta-glucan induced trained immunity enhances antibody levels in a vaccination model in mice.
    PLoS One. 2025;20:e0323376.
    >> Share

  134. YAN X, Liu Y, Chen F, Chang Z, et al
    The efficacy and effectiveness of enterovirus A71 vaccines against hand, foot, and mouth disease: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0323782.
    >> Share

  135. OVER D, Santana E, Amaral EFL, Lakkimsetti C, et al
    A comprehensive analysis of COVID-19 vaccination behavior: The influence of religion, information sources, political leanings, and demographic factors.
    PLoS One. 2025;20:e0323815.
    >> Share

  136. WARD CL, Rojas Castro MY, Chakhunashvili G, Chitadze N, et al
    COVID-19 vaccine effectiveness among healthcare workers during the Omicron period in the country of Georgia, January - June 2022.
    PLoS One. 2025;20:e0311337.
    >> Share

  137. WU H, He X, Cao Y, Gao W, et al
    Adverse events affecting recovery from seasonal influenza vaccination in the hypertensive population: A population-based pharmacovigilance analysis.
    PLoS One. 2025;20:e0310474.
    >> Share

  138. SAMARA KA, Barqawi HJ, Alhayali DM, Kannas SM, et al
    Evaluation of knowledge, attitudes and vaccine hesitancy towards MMR vaccine among parents in the United Arab Emirates.
    PLoS One. 2025;20:e0324629.
    >> Share

  139. JONGKEES MJ, Bogers S, de Vries RD, GeurtsvanKessel CH, et al
    Longitudinal assessment of COVID-19 vaccine immunogenicity in people with HIV stratified by CD4+ T-cell count in the Netherlands: A two-year follow-up study.
    PLoS One. 2025;20:e0323792.
    >> Share

  140. PUCA C, Wood-Kenney P, Nelson N, Hansen J, et al
    "Our kids are our future": Barriers and facilitators to vaccine uptake and timeliness among Aboriginal children younger than five years in Boorloo (Perth), Western Australia.
    PLoS One. 2025;20:e0317946.
    >> Share

  141. PARIDANS M, Dardenne N, Gillain N, Husson E, et al
    Removing barriers to COVID-19 vaccine intention in a university population: Results of a serial mediation study through the dimensions of the Health Belief Model.
    PLoS One. 2025;20:e0322881.
    >> Share

  142. DORJEE K, Sadoff RC, Mansour FR, Dorjee S, et al
    Menstrual disturbance associated with COVID-19 vaccines: A comprehensive systematic review and meta-analysis.
    PLoS One. 2025;20:e0320162.
    >> Share

  143. HAU SJ, Fittipaldi N, Payen S, Grenier D, et al
    Protection induced in pigs previously infected by the non-virulent strain 1330 of Streptococcus suis serotype 2 is not due to the secretion of the bacteriocin suicin.
    PLoS One. 2025;20:e0323370.
    >> Share

  144. BHAT KD, Bhattacharya H, Jayaraman Y, Kanungo S, et al
    Hepatitis B virus infection among children aged 1- 5 years of Mayurbhanj district (Odisha), India: A prospective study protocol.
    PLoS One. 2025;20:e0317621.
    >> Share

  145. SONG MC, Ha J, Park S, Kang H, et al
    Mortality in severe serious adverse events following heterologous and homologous prime-boost vaccination strategies for SARS-CoV-2: A retrospective cohort study.
    PLoS One. 2025;20:e0323736.
    >> Share

  146. NATALIA YA, Molenberghs G, Neyens T, Hens N, et al
    Empirical analysis of COVID-19 confirmed cases, hospitalizations, vaccination, and international travel across Belgian provinces in 2021.
    PLoS One. 2025;20:e0322017.
    >> Share

  147. PODDA M, Savojardo C, Luigi Martelli P, Casadio R, et al
    A descriptor-free machine learning framework to improve antigen discovery for bacterial pathogens.
    PLoS One. 2025;20:e0323895.
    >> Share

  148. HARTVIGSEN G, Dimitroff Y
    Modeling the SARS-CoV-2 epidemic and the efficacy of different vaccines across different network structures.
    PLoS One. 2025;20:e0325129.
    >> Share

  149. CARAZO S, Skowronski DM, Brousseau N, Guay CA, et al
    Monovalent mRNA XBB.1.5 vaccine effectiveness against COVID-19 hospitalization in Quebec, Canada: Impact of variant replacement and waning protection during 10-month follow-up.
    PLoS One. 2025;20:e0325269.
    >> Share

  150. FATIREGUN AA, Nic Lochlainn L, Kabore L, Dosumu M, et al
    Correction: Missed opportunities for vaccination among children aged 0-23 months visiting health facilities in a southwest State of Nigeria, December 2019.
    PLoS One. 2025;20:e0325918.
    >> Share

  151. CAHN P, Barreto L, Figueroa MI, Fink V, et al
    Immune response induced by the recombinant novel coronavirus vaccine (Adenovirus type 5 vector) (Ad5-nCoV) in persons living with HIV (PLWH).
    PLoS One. 2025;20:e0312893.
    >> Share

  152. LI L, Back SI, Ma J, Guo Y, et al
    Bayesian optimization and machine learning for vaccine formulation development.
    PLoS One. 2025;20:e0324205.
    >> Share

  153. ATAC O, Peterson LE, Waters TM
    The impact of the COVID-19 pandemic on vaccinations in United States primary care practices.
    PLoS One. 2025;20:e0325934.
    >> Share

  154. ENYEW EB, Kasaye MD, Kebede SD, Feyisa MS, et al
    Human Papillomavirus Vaccination uptake and associated factors among schools girls aged between 9-14 years in Ethiopia: Performance Monitoring for Action (PMA-ET) 2023, multilevel analysis.
    PLoS One. 2025;20:e0325557.
    >> Share

  155. KUATEWO M, Ebelin W, Doegah PT, Aberese-Ako M, et al
    Fake news, misinformation, vaccine hesitancy and the role of community engagement in COVID-19 vaccine acceptance in Southern Ghana.
    PLoS One. 2025;20:e0316969.
    >> Share

  156. LOGANATHAN T, Zaini AZ, Majid HA
    Exploring the barriers and facilities migrants face in accessing COVID-19 vaccines in Malaysia: A qualitative study.
    PLoS One. 2025;20:e0326045.
    >> Share

  157. BURHAN E, Azzumar F, Sinuraya FAG, Prasetyo S, et al
    Vaccine effectiveness of inactivated and mRNA COVID-19 vaccine platform during Delta and Omicron wave in Jakarta, Indonesia: A test-negative case-control study.
    PLoS One. 2025;20:e0320779.
    >> Share

  158. ZHANG J, Cao Y, Jin Z, A R, et al
    Dynamic CYP2E1 expression and metabolic activity changes in male rats during immune liver injury and sex differences in alcohol metabolism.
    PLoS One. 2025;20:e0325135.
    >> Share

  159. YANG Y, Lu Y, Li Y, Qin C, et al
    Factors affecting caregivers' HPV vaccination decisions for adolescent girls: A secondary analysis of a Chinese RCT.
    PLoS One. 2025;20:e0324260.
    >> Share

  160. NOFZINGER TB, Huang TT, Lingat CER, Amonkar GM, et al
    Vaccine fatigue and influenza vaccination trends across Pre-, Peri-, and Post-COVID-19 periods in the United States using epic's cosmos database.
    PLoS One. 2025;20:e0326098.
    >> Share

  161. ZHANG C, Liu Y, Luo X, Han L, et al
    Real-world safety profile of live attenuated Japanese encephalitis vaccine before and after the vaccine administration law.
    PLoS One. 2025;20:e0326257.
    >> Share

  162. BEKUMA TT, Seme A, Ahmed S, Abera M, et al
    Level and determinants of pentavalent vaccine dropout during infancy: A hierarchical analysis of community-level longitudinal study.
    PLoS One. 2025;20:e0326684.
    >> Share

  163. AUNG KT, Htun YM, Htet ZL, Soe YNM, et al
    Parental hesitancy on COVID-19 vaccination of children under the age of 16: A cross-sectional mixed-methods study among factory workers.
    PLoS One. 2025;20:e0327056.
    >> Share

  164. LEMEY G, Lariviere Y, Milolo S, Zola Matuvanga T, et al
    "We have to amplify what we saw at EBOVAC" - Assessing participant perceptions, attitudes, and acceptability of an ancillary care policy in an Ebola vaccine trial in the Democratic Republic of the Congo: A mixed methods study.
    PLoS One. 2025;20:e0325435.
    >> Share

  165. PALENA G, Stilo I, Sorrentino M, Fiorilla C, et al
    Organizational barriers in HPV vaccination uptake: A cross-sectional study among health sciences students.
    PLoS One. 2025;20:e0326694.
    >> Share

  166. ALMOFTI YA, Ibrahim AA, Mahmoud NA, Elshafei AM, et al
    Exploring varicella zoster virus proteome for construction and validation of a multi-epitope based subunit vaccine using multifaceted immunoinformatics approaches.
    PLoS One. 2025;20:e0324453.
    >> Share

  167. YANG X, Zheng J, Lv X, Wang Q, et al
    Uptake, knowledge, attitudes, and practices toward seasonal influenza vaccination among community healthcare workers during the COVID-19 pandemic in Chongqing Municipality, China: A cross-sectional study.
    PLoS One. 2025;20:e0327012.
    >> Share

  168. EBERWEIN AE, Cummings PR, Cummings D, Andre J, et al
    Hepatitis B (HBsAg) prevalence among obstetric patients in Caluquembe, Angola, 2023-2024.
    PLoS One. 2025;20:e0327426.
    >> Share

  169. TAREQ MMI, Biswas S, Rahman FA, Siam LS, et al
    Development of a potential vaccine against Capripox virus implementing reverse vaccinology and pan-genomic immunoinformatics.
    PLoS One. 2025;20:e0326310.
    >> Share

  170. FOURNAIS LA, Zimakoff AC, Jensen A, Svanholm JH, et al
    Measles vaccines and non-specific effects on mortality or morbidity: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0321982.
    >> Share

  171. FRANKENTHAL D, Zatlawi M, Karni-Efrati Z, Keinan-Boker L, et al
    Evaluation of adverse events and comorbidity exacerbation following the COVID-19 booster dose: A national survey among randomly-selected booster recipients.
    PLoS One. 2025;20:e0326231.
    >> Share

  172. HASAN MM, Islam MH
    Herd immunity and prevention in HPV transmission with exogenous reinfection.
    PLoS One. 2025;20:e0327233.
    >> Share

  173. LEYVA-FLORES R, Aracena-Genao B, Allen C, Gomez-Lopez D, et al
    Examining COVID-19 vaccination coverage and acceptability among migrants in transit through Mexico during 2021-2022: Insights from shelter surveys and interviews.
    PLoS One. 2025;20:e0324325.
    >> Share

  174. BREWER SE, Bertin KB, Suresh K, LoudHawk-Hedgepeth C, et al
    Correction: Factors in COVID-19 vaccine uptake in five racial/ethnic Colorado communities: A report from the Colorado CEAL project.
    PLoS One. 2025;20:e0328097.
    >> Share

  175. AGHA S, Nsofor I
    HPV vaccine uptake among adolescent girls in Nigeria: The complex role of caregivers' education.
    PLoS One. 2025;20:e0325684.
    >> Share

  176. PATEL C, Bilgin G, Hayen A, Kirk M, et al
    The association between routine immunisation and COVID-19 vaccination in small Island developing states.
    PLoS One. 2025;20:e0317327.
    >> Share

  177. DE ANDRADE PEREIRA SILVA M, Pelloso FC, Carvalho MDB, Oliveira RR, et al
    Effect of COVID-19 vaccination on the incidence, lethality and mortality of pregnant and postpartum women.
    PLoS One. 2025;20:e0327207.
    >> Share

  178. BROWN DR, Cyr DD, Wruck L, Stefano TA, et al
    COVID-19 prevention is shaped by polysocial risk: A cross-sectional study of vaccination and testing disparities in underserved populations.
    PLoS One. 2025;20:e0328779.
    >> Share

  179. ALMUALLEM NA, Chauhan RP
    Effects of quarantine and vaccination on the transmission of Lumpy skin disease: A fractional approach.
    PLoS One. 2025;20:e0327673.
    >> Share

  180. MAGNUS KD, Dammann N, Ludecke D
    Vaccination readiness and political party preference in Germany: Trust, collective responsibility, and the populist radical right.
    PLoS One. 2025;20:e0328045.
    >> Share

  181. DARAGHMEH DN, Salah A, Hamdan N, Zamareh A, et al
    Attitudes, beliefs, and practices regarding complementary and alternative medicine use: Influenza vaccine intake.
    PLoS One. 2025;20:e0320412.
    >> Share

  182. BENEDETTI JEV, Pizzutti K, Mott MP, Vieira PUP, et al
    Post-vaccination Streptococcus pneumoniae colonization and respiratory manifestations in children: A prospective cohort study.
    PLoS One. 2025;20:e0328516.
    >> Share

  183. SMITH GC, Budgey R
    Bovine tuberculosis model validation against a field study of badger vaccination with selective culling.
    PLoS One. 2025;20:e0320830.
    >> Share

  184. MARINAIK CB, Lakshmikanth BT, Siddaramegowda CK, Rizwan A, et al
    Adjuvantation of Kyasanur Forest Disease vaccine with TLR9 agonist CpG adjuvant enhances immunological efficacy and potency of the vaccine.
    PLoS One. 2025;20:e0329348.
    >> Share

  185. CORONELL-RODRIGUEZ W, Camerano R, Alvarado-Gonzalez JC, Puerto A, et al
    Evaluation of Streptococcus pneumoniae as a cause of acute otitis media in Colombia: A prospective study.
    PLoS One. 2025;20:e0326660.
    >> Share

  186. GEBRETNSAE H, Ayele B, Gebresilassie F, Hadgu T, et al
    Vaccination status and its determinants among children aged 12-23 months in Tigray, northern Ethiopia: A zero-inflated Poisson regression analysis.
    PLoS One. 2025;20:e0327854.
    >> Share

  187. MOHAMED PAUZI MH, Abdul Kadir A, Muhamad R, Mat Yudin Z, et al
    A qualitative study on barriers and facilitators of COVID-19 vaccination during pregnancy among pregnant women in Malaysia.
    PLoS One. 2025;20:e0329895.
    >> Share

  188. FERCHIOU A, Giacomini A, Herman N, Lhermie G, et al
    Economics of vaccination against diarrhoea and respiratory diseases in French cow calves' systems: A modelling approach.
    PLoS One. 2025;20:e0329325.
    >> Share

  189. XIA D, Su Y, Song M, Zhu T, et al
    The influence of audience's regulatory focus on the persuasive effect of different pro-vaccine messages.
    PLoS One. 2025;20:e0328638.
    >> Share

  190. ILYASOVA AA, Queen TL, Gilkey M, Fogel BN, et al
    Use of presumptive recommendations and other strategies to encourage HPV vaccine uptake: Results from a national survey of primary care health professionals.
    PLoS One. 2025;20:e0327872.
    >> Share

  191. PRASERT K, Praphasiri P, Ditsungnoen D, Srichaijaroonpong S, et al
    Perceptions of influenza and SARS-CoV-2 vaccination among health care personnel in Thailand, 2024.
    PLoS One. 2025;20:e0329473.
    >> Share

  192. TOUZET H, Privault S, Ward JK
    The role of professional socialisation in confidence in vaccines and vaccination decision-makers: Insights from a large multi-wave survey in France.
    PLoS One. 2025;20:e0328548.
    >> Share

  193. WYPLOSZ B, Grenier B, Roche N, Roubille F, et al
    Pneumococcal vaccination at 65 years and vaccination coverage in at-risk adults: A retrospective population-based study in France.
    PLoS One. 2025;20:e0329703.
    >> Share

  194. LEUNG T, Ferrari M
    Bias in the estimated reporting fraction due to vaccination in the time-series SIR model.
    PLoS One. 2025;20:e0330568.
    >> Share

  195. LEONHARD AK, Badre-Esfahani SK, Larsen MB, Petersen LK, et al
    "Two shots for life. HPV-vaccination at your school". Co-creation of a complex intervention to reduce ethnic inequity in childhood HPV-vaccination in Denmark.
    PLoS One. 2025;20:e0323870.
    >> Share

  196. KARACHALIOU PRASINOU A, Trotter C
    Modelling of strategies for the introduction and routine use of multivalent meningococcal conjugate vaccines (MMCVs) in the African meningitis belt.
    PLoS One. 2025;20:e0330627.
    >> Share

  197. PUGGINA A, Marijam A, Cailloux O, Vicentini M, et al
    Physician knowledge, attitudes, and perceptions of respiratory syncytial virus in older adults: A cross-sectional survey in Germany and Italy.
    PLoS One. 2025;20:e0330763.
    >> Share

  198. KASSA B, Mohammed A, Wassie GT
    Parents' acceptance of human papilloma virus vaccination for their daughters in adet town, North Gojjam zone, Northwest Ethiopia: A mixed method study.
    PLoS One. 2025;20:e0330911.
    >> Share

  199. FISMAN DN, Amoako A, Simmons A, Tuite AR, et al
    Correction: Impact of immune evasion, waning and boosting on dynamics of population mixing between a vaccinated majority and unvaccinated minority.
    PLoS One. 2025;20:e0330965.
    >> Share

  200. DEN'O ZD, Paulos W, Markos D, Oche WO, et al
    Human papilloma virus vaccination uptake and associated factors among adolescent girls in Merab Abaya district, Gamo zone, Southern Ethiopia: Mixed methods.
    PLoS One. 2025;20:e0330760.
    >> Share

  201. CATES ZP, Facciuolo A, Scruten E, Kusalik A, et al
    Peptide immunoarrays for rationale development of vaccines with enhanced cross-reactivity.
    PLoS One. 2025;20:e0330741.
    >> Share

  202. MOTAMEDI H, Shoja S, Abbasi M
    Correction: Immunoinformatic evaluation for the development of a potent multi-epitope vaccine against bacterial vaginosis caused by Gardnerella vaginalis.
    PLoS One. 2025;20:e0331745.
    >> Share

  203. STRBAC M, Ukropina S, Nikolic N, Masic K, et al
    Impact of health promotion strategies on HPV vaccination uptake: A descriptive epidemiological study (2019-2024).
    PLoS One. 2025;20:e0331592.
    >> Share

  204. SEMANCIK CS, Fantin R, Butt J, Abdelnour A, et al
    SARS-CoV-2 antibody and neutralization dynamics among persons with natural- and vaccine-induced exposures.
    PLoS One. 2025;20:e0331212.
    >> Share

  205. VISKUPIC F, Wiltse DL, Stenvig TE
    Nurses' attitudes about RSV vaccination for pregnant women and infants: Evidence from a cross-sectional survey.
    PLoS One. 2025;20:e0331326.
    >> Share

  206. STOLARCZUK JE, Sosa M, Pike M, Baranoff A, et al
    Transplacental transfer of maternal SARS-CoV-2 antibodies in dichorionic and monochorionic twin pregnancies.
    PLoS One. 2025;20:e0328137.
    >> Share

  207. ENDEHABTU BF, Alemu K, Mengiste SA, Zelalem M, et al
    Spatial disparities in zero-dose vaccination coverage for children aged 12-23 months in Ethiopia: A geographically weighted regression analysis.
    PLoS One. 2025;20:e0332162.
    >> Share

  208. DELL'ANTONIO CSDS, Bierrenbach AL
    Epidemiological patterns of SARS-CoV-2 reinfections in Espirito Santo, Brazil: A population-based analysis using integrated surveillance and vaccination data.
    PLoS One. 2025;20:e0331771.
    >> Share

  209. PHIRI MM, Osman R, Weldegebriel S, Sabola S, et al
    Exploration of the social determinants of diarrhoea, rotavirus vaccine uptake, and vaccine 'fatigue' in Ethiopia, Kenya, and Malawi.
    PLoS One. 2025;20:e0319691.
    >> Share

  210. MARFOH K, Samba A, Okyere E, Fattah AZ, et al
    Post-vaccination SARS-CoV-2 infections among healthcare workers in a tertiary hospital in Ghana.
    PLoS One. 2025;20:e0331971.
    >> Share

  211. POKU CA, Owusu GA, Gyamfuah P, Addae G, et al
    Determinants of vaccination uptake among pregnant women in Kumasi: A multi-centre cross-sectional study.
    PLoS One. 2025;20:e0332425.
    >> Share

  212. WANG Y, Gao YD, Jiang CH, Xi Y, et al
    Characterisation of a novel chicken-derived H3N3 avian influenza virus detected in China in 2023: Pathogenicity and immunogenicity.
    PLoS One. 2025;20:e0332213.
    >> Share

  213. BASHORUN AO, Kotei L, Jallow AF, Jawla O, et al
    Human papillomavirus, sexually transmitted infections, and antimicrobial resistance in West Africa: Estimating population burden and understanding exposures to accelerate vaccine impact and drive new interventions: The PHASE survey protocol.
    PLoS One. 2025;20:e0332842.
    >> Share

  214. PAYNE LA, Edelman A, Darney BG, Benhar E, et al
    Brief report: Older adolescents and young adults may be at higher risk for changes to menstrual cycle length with COVID-19 vaccination.
    PLoS One. 2025;20:e0331346.
    >> Share

  215. POLISHCHUK V, Kostinov capital EM, Cyrillic, Ryzhov capital A, Cyrillic, Dagil Y, et al
    Immunogenicity of one dose and two doses of adjuvanted influenza vaccine in lung transplant candidates.
    PLoS One. 2025;20:e0332346.
    >> Share

  216. CHAUFAN C
    How did Ontario healthcare institutions implement and legitimize Covid-19 vaccine mandates? A qualitative multi?method study protocol.
    PLoS One. 2025;20:e0332589.
    >> Share

  217. KUMAR D, Sagar V, Kujur A, Bhardwaj S, et al
    Identifying key predictors amongst children of under 5 years of age with fever and rashes amidst measles outbreak in Jharkhand: A case control study.
    PLoS One. 2025;20:e0333381.
    >> Share

  218. SEFAH IA, Ofori P, Hutton-Nyameaye A, Yamoah P, et al
    COVID-19 vaccine hesitancy and its predictors among healthcare workers in a tertiary hospital in Ghana: A cross-sectional survey.
    PLoS One. 2025;20:e0333412.
    >> Share

  219. JORDAN S, Bottger SJ, Zinn S
    The persuasiveness of different sources of information on the decision to vaccinate. A cross-sectional study in Germany during the pandemic at the turn of the year 2021/2022.
    PLoS One. 2025;20:e0333268.
    >> Share

  220. FORTUNATO P, Lombini A
    Behind political affiliation: How moral values, identity politics, and party loyalty have affected COVID-19 vaccination.
    PLoS One. 2025;20:e0330881.
    >> Share

  221. CHEMAITELLY H, Ayoub HH, Coyle P, Tang P, et al
    Evaluating the cost-effectiveness of COVID-19 mRNA primary-series vaccination in Qatar: An integrated epidemiological and economic analysis.
    PLoS One. 2025;20:e0331654.
    >> Share

  222. TOGEL J, Kuhbandner C
    COVID-19 vaccinations among German university students: The role of fear of COVID-19 and risk assessment.
    PLoS One. 2025;20:e0333082.
    >> Share

  223. SMITH LM, Kartal T, Rawat S, Chaudhari A, et al
    Changes in free-roaming dog population demographics and health associated with a catch-neuter-vaccinate-release program in Jamshedpur, India.
    PLoS One. 2025;20:e0317636.
    >> Share

  224. HOSSEN MT, Alam MSB, Islam MS, Montomoli E, et al
    Impact of the COVID-19 pandemic on the routine immunization system in Bangladesh.
    PLoS One. 2025;20:e0334503.
    >> Share

  225. CHOU HH, Chu PY, Wu YH, Feng C, et al
    Health impact and cost-effectiveness analysis of gender-neutral versus female-only 9-valent human papillomavirus vaccination in Taiwan.
    PLoS One. 2025;20:e0333757.
    >> Share

  226. BEKUMA TT, Seme A, Ahmed S, Abera M, et al
    Correction: Level and determinants of pentavalent vaccine dropout during infancy: A hierarchical analysis of community-level longitudinal study.
    PLoS One. 2025;20:e0334536.
    >> Share

  227. NADERIAN R, Ahmad S, Rahmanian M, Aghaamoo S, et al
    Rational design of multi-epitope vaccine for Chandipura virus using an immunoinformatics approach.
    PLoS One. 2025;20:e0335147.
    >> Share

  228. KONOMI F, Bino S, Mersini K, Ramaj A, et al
    COVID-19 breakthrough infections during the circulation of Delta and Omicron variants in Tirana, Albania, April 2021-March 2022.
    PLoS One. 2025;20:e0335197.
    >> Share


  229. Correction: Messages that increase COVID-19 vaccine acceptance: Evidence from online experiments in six Latin American countries.
    PLoS One. 2025;20:e0335673.
    >> Share

  230. EPAULARD O, Carre M, Hermet E, Corbin V, et al
    Antibody response to tetanus, diphtheria, poliomyelitis, hepatitis B, and H. influenzae b vaccines in allogeneic hematopoietic stem cell transplant adult recipients: A multicenter trial.
    PLoS One. 2025;20:e0335224.
    >> Share

  231. NIROB MNH, Sultana I, Al Arian T, Islam MS, et al
    A multi-epitope vaccine targeting a key virulence factor ClfA: An In-silico approach to combat Staphylococcus aureus infections.
    PLoS One. 2025;20:e0334885.
    >> Share

  232. LI C, Zhu Y, Qi X, Chai Z, et al
    Design of a multi-epitope recombinant BCG vaccine targeting Brucella OMP31, LptE and VirB2 in immunoinformatics approaches.
    PLoS One. 2025;20:e0334843.
    >> Share

  233. FEKRI M, Bolhassani A, Movahedi M, Rahmati F, et al
    Simultaneous efficacy of IL-15 and the HSP70 fragments in increasing immunostimulatory effects of a HIV-1 DNA vaccine candidate against SCR HIV-1.
    PLoS One. 2025;20:e0336042.
    >> Share

  234. AYOUNI I, Githaiga JN, Amponsah-Dacosta E, Kagina BM, et al
    Adapting the WHO Behavioural and Social Drivers of Vaccination (BeSD) tools and Vaccination Attitudes Examination (VAX) scale for pregnant women in South Africa: Insights from a mixed-methods pilot study.
    PLoS One. 2025;20:e0334854.
    >> Share

  235. POWELL A, Van Hout MC, Connors D, Montgomery C, et al
    A thematic analysis of flu vaccine hesitance in ethnically minoritised communities in Liverpool.
    PLoS One. 2025;20:e0333602.
    >> Share

  236. KOSTRZEWA M, Sadat Seyyedsalehi M, Godono A, Collatuzzo G, et al
    Cancer Prevention at Work (CPW) project: Rationale, framework and research protocol.
    PLoS One. 2025;20:e0335752.
    >> Share

  237. LU M, Bu Z, Xiang N, Yu J, et al
    Association between COVID-19 vaccination and atopic diseases in US adults: A retrospective cohort study.
    PLoS One. 2025;20:e0336698.
    >> Share

  238. EZEZIKA O, Kotsaftis TS, Amponsah-Dacosta E, Demi S, et al
    Correction: A protocol for modeling the factors influencing the deployment of the COVID-19 vaccine across African countries.
    PLoS One. 2025;20:e0336507.
    >> Share

  239. FU K, Jackson DB, Testa A
    Adverse childhood experiences and COVID-19 vaccination uptake: Examining the intersection of sex and urban-rural residence.
    PLoS One. 2025;20:e0336390.
    >> Share

  240. TSEGAW TK, Alemu EA, Arage FG, Tadese ZB, et al
    Geographically weighted regression analysis of incomplete basic childhood vaccination in Sub-Saharan Africa: Evidence from DHS, 2019-2024.
    PLoS One. 2025;20:e0336498.
    >> Share

  241. LIMTHONGKUL J, Warit S, Sunintaboon P, Ubol S, et al
    BCG cell wall skeleton augments the immunogenicity of dengue nanoparticle vaccines by promoting dendritic cell activation.
    PLoS One. 2025;20:e0337113.
    >> Share

  242. SETHI G, Lakra AK, Nirmal K, Hwang JH, et al
    In silico design of a multi-epitope vaccine against Cryptosporidium parvum using structural and immunoinformatics approaches.
    PLoS One. 2025;20:e0334754.
    >> Share

  243. FISHER SS, Lindaas A, Muthuri SG, Lloyd PC, et al
    Risk of neurologic or immune-mediated adverse events after COVID-19 diagnosis in the United States.
    PLoS One. 2025;20:e0333704.
    >> Share

  244. LEET DE, Jin J, Craik CS, Kattah MG, et al
    Post-vaccination SARS-CoV-2 neutralizing antibodies in pregnant women receiving biologics for inflammatory bowel disease.
    PLoS One. 2025;20:e0321242.
    >> Share

  245. EL-AKKAD SE, Shao S, Tran KC, Naik H, et al
    Association between COVID-19 vaccination, SARS-CoV-2 variants, and post COVID-19 condition: A cross-sectional study.
    PLoS One. 2025;20:e0336929.
    >> Share

  246. LI M, Liang L, Chen X, Zhu Z, et al
    Bridging knowledge gaps: An observational study on HPV awareness and misconceptions among young adults in China.
    PLoS One. 2025;20:e0337518.
    >> Share

  247. HUSSEIN M, Gebreal A, Naeem A, AboElela AM, et al
    Cross-national disparities in healthcare workers' perceptions: Examining fear of infection and confidence in the received COVID-19 vaccines amid emerging variants.
    PLoS One. 2025;20:e0318788.
    >> Share

  248. SADEH S, Ghaemi A, Soleimani NA, Moghbeli M, et al
    Designing influenza virus-derived cell-penetrating peptides for antigen delivery: Integrating uptake efficiency, safety, and receptor targeting.
    PLoS One. 2025;20:e0338028.
    >> Share

  249. MACIEL PS, Almeida GG, Carvalho GBF, Silva-Pereira RAD, et al
    Exploring the immune responses triggered by vaccine formulations containing the recombinant Schistosoma mansoni 14kDa fatty acid-binding protein.
    PLoS One. 2025;20:e0338310.
    >> Share

  250. ELMANZLAWEY M, Terra M, Baklola M, Ahmed Y, et al
    Awareness, knowledge, and beliefs about Human Papillomavirus and its vaccine among Egyptian medical students: A cross-sectional national study.
    PLoS One. 2025;20:e0337411.
    >> Share

  251. COUDERT JF, Dadachova E, Maignant G, Jonathan S, et al
    Radon exposure and COVID-19 mortality in pre-vaccination period: What links might exist?
    PLoS One. 2025;20:e0337320.
    >> Share

  252. FREY LJ, Banasiewicz KE, Ruckes C, Wagner I, et al
    Complications and oncologic outcome in bladder cancer patients receiving radical cystectomy after intravesical instillation treatment.
    PLoS One. 2025;20:e0337644.
    >> Share

  253. COSTA T
    The impossible confounder: Quantifying the limits of alternative explanations for COVID-19 vaccine effectiveness.
    PLoS One. 2025;20:e0336063.
    >> Share

  254. GYAWALI N, Caragea D, Caragea C, Mohammad SM, et al
    The shifting landscape of vaccine discourse: Insights from a decade of pre- to post-COVID-19 vaccine posts on social media.
    PLoS One. 2025;20:e0337911.
    >> Share

  255. ARAUJO JIF, Batista FAM, De Souto Medeiros MR, Sena BO, et al
    The use of social media as an influence on vaccination rates: A systematic review protocol.
    PLoS One. 2025;20:e0334114.
    >> Share

  256. BARDACH A, Berrueta M, Ciapponi A, Sambade JM, et al
    Efficacy, safety, and immunogenicity of Lassa fever vaccines: A living systematic review and landscape analysis of vaccine candidates.
    PLoS One. 2025;20:e0338128.
    >> Share

  257. OH YJ, Rasul ME, Lim JI, Calabrese C, et al
    Targeting anger for COVID-19 prevention: The motivating role of anger on media use and vaccination intention.
    PLoS One. 2025;20:e0338183.
    >> Share

  258. LEE J, Park J, La TM, Hyeon JY, et al
    Genomic insights into the expansion of meropenem-resistant GPSC1-CC320 Streptococcus pneumoniae serotype 19A isolates from children under 5 years of age with invasive infections, 2018-2024.
    PLoS One. 2025;20:e0325870.
    >> Share

  259. ALOTAIBI BS, Khan F, Rehmani MBI, Arshad F, et al
    In-silico core proteome analysis for chimeric vaccine development against tick-borne tularemia.
    PLoS One. 2025;20:e0337692.
    >> Share

  260. BHATTACHARYA A, Mark-Uchendu C, Hansen C, Evans J, et al
    Systematic review of mHealth and digital health interventions to improve childhood vaccination uptake in 19 Sub-Saharan African countries.
    PLoS One. 2025;20:e0324117.
    >> Share

    January 2024
  261. ABER JO, Bongomin F, Opio SL, Ochola E, et al
    Hepatitis B vaccine uptake and associated factors among adults of Gulu city in Northern Uganda: A community-based cross-sectional study.
    PLoS One. 2024;19:e0297617.
    >> Share

  262. HOU Y, Bidkhori H
    Multi-feature SEIR model for epidemic analysis and vaccine prioritization.
    PLoS One. 2024;19:e0298932.
    >> Share


  263. Retraction: Properly Folded Bacterially Expressed H1N1 Hemagglutinin Globular Head and Ectodomain Vaccines Protect Ferrets against H1N1 Pandemic Influenza Virus.
    PLoS One. 2024;19:e0300096.
    >> Share

  264. KONLAN MY, Mahama F, Abubakari BB, Konka P, et al
    Predictors of vaccination card retention in Tamale Metropolis, Ghana.
    PLoS One. 2024;19:e0292765.
    >> Share

  265. DIAS E, Diniz AMA, Souto GR, Guerra HL, et al
    Predicting COVID-19 cases in Belo Horizonte-Brazil taking into account mobility and vaccination issues.
    PLoS One. 2024;19:e0269515.
    >> Share

  266. BASHIR IM, Al-Waleedi AA, Al-Shaibani SM, Rajamanar M, et al
    Strengthening laboratories in response to outbreaks in humanitarian emergencies and conflict settings: Results, challenges and lessons from expanding PCR diagnostic capacities for COVID-19 testing in Yemen.
    PLoS One. 2024;19:e0298603.
    >> Share

  267. WU S, Li Y, Baral S, Mishra S, et al
    Protection of prior SARS-CoV-2 infection, COVID-19 boosters, and hybrid immunity against Omicron severe illness: A population-based cohort study of five million residents in Canada.
    PLoS One. 2024;19:e0299304.
    >> Share

  268. SENJAM SS, Manna S, Goel G, Balhara YPS, et al
    Vaccination coverage against COVID-19 among rural population in Haryana, India: A cross-sectional study.
    PLoS One. 2024;19:e0299564.
    >> Share

  269. TANNER AE, Hall MA, Aguilar-Palma SK, Mann-Jackson L, et al
    Understanding uptake of COVID-19 testing, vaccination, and boosters among Spanish-speaking Latines in the United States: Qualitative insights from Spanish speakers and key informants.
    PLoS One. 2024;19:e0296812.
    >> Share

  270. GIANNOUCHOS TV, Hair NL, Olatosi B, Li X, et al
    Waning effectiveness of mRNA COVID-19 vaccines against inpatient and emergency department encounters.
    PLoS One. 2024;19:e0300198.
    >> Share

  271. ZHANG X, Han X, Chen B, Fu X, et al
    Influence of nutritional supplements on antibody levels in pregnant women vaccinated with inactivated SARS-CoV-2 vaccines.
    PLoS One. 2024;19:e0289255.
    >> Share

  272. AGIMAS MC, Alemayehu MA, Derseh NM, Aragaw FM, et al
    Correction: Spatial pattern and associated factors of timely vaccination in Ethiopia using EDHS-2016 data: A multilevel and spatial analysis.
    PLoS One. 2024;19:e0300482.
    >> Share

  273. MALITA MA, Manolescu LSC, Perieanu VS, Babiuc I, et al
    COVID-19 and flu vaccination in Romania, post pandemic lessons in healthcare workers and general population.
    PLoS One. 2024;19:e0299568.
    >> Share

  274. WILLIAMS SV, Akande T, Abbas K
    Systematic review of social determinants of childhood immunisation in low- and middle-income countries and equity impact analysis of childhood vaccination coverage in Nigeria.
    PLoS One. 2024;19:e0297326.
    >> Share

  275. KECHAGIAS KS, Laleye JD, Drmota J, Geropoulos G, et al
    Minimal change disease following COVID-19 vaccination: A systematic review.
    PLoS One. 2024;19:e0297568.
    >> Share

  276. SCHRIJVERS-GONLAG M, Skarpe C, Julkunen-Tiitto R, Poleo ABS, et al
    Phenolic concentrations and carbon/nitrogen ratio in annual shoots of bilberry (Vaccinium myrtillus) after simulated herbivory.
    PLoS One. 2024;19:e0298229.
    >> Share

  277. ARUMAE K, Realo A, Ausmees L, Allik J, et al
    Self- and informant-reported personality traits and vaccination against COVID-19.
    PLoS One. 2024;19:e0287413.
    >> Share

  278. SUWANBAMRUNG C, Srinam B, Promkool P, Suwannakarn W, et al
    Uptake of COVID-19 vaccine among high-risk urban populations in Southern Thailand using the COM-B model.
    PLoS One. 2024;19:e0300509.
    >> Share

  279. PANG Y, Robbs C, Wang J
    A longitudinal study of the COVID-19 pandemic impact on mental health in ophthalmic personnel and students.
    PLoS One. 2024;19:e0300144.
    >> Share

  280. TOWNSLEY H, Gahir J, Russell TW, Greenwood D, et al
    COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history.
    PLoS One. 2024;19:e0294897.
    >> Share

  281. LEE DH, Lee SH, Kim AR, Quan FS, et al
    Correction: Virus-Like Nanoparticle Vaccine Confers Protection against Toxoplasma gondii.
    PLoS One. 2024;19:e0301214.
    >> Share

  282. LI Y, Li J, He J, Tao C, et al
    AE-GPT: Using Large Language Models to extract adverse events from surveillance reports-A use case with influenza vaccine adverse events.
    PLoS One. 2024;19:e0300919.
    >> Share

  283. LANZA-LEON P, Cantarero-Prieto D, Pascual-Saez M
    Exploring trends and determinants of basic childhood vaccination coverage: Empirical evidence over 41 years.
    PLoS One. 2024;19:e0300404.
    >> Share

  284. GUERRERIO AL, Mateja A, MacCarrick G, Fintzi J, et al
    Web-based survey investigating cardiovascular complications in hypermobile Ehlers-Danlos syndrome after COVID-19 infection and vaccination.
    PLoS One. 2024;19:e0298272.
    >> Share

  285. ZHENG D, Sun Q, Su Z, Kong F, et al
    Correction: Enhancing Specific-Antibody Production to the ragB Vaccine with GITRL That Expand Tfh, IFN-gamma+ T Cells and Attenuates Porphyromonas gingivalis Infection in Mice.
    PLoS One. 2024;19:e0301151.
    >> Share

  286. KOSKAN A, Larkey L, Todd M, Kim SW, et al
    Protocol for a community-based digital storytelling pilot intervention to reduce Hispanic parents' vaccine hesitancy to immunize their children against COVID-19.
    PLoS One. 2024;19:e0299787.
    >> Share

  287. TRZEBINSKI W, Trzebinski J
    How does collectivism help deal with perceived vaccine artificiality? The case of COVID-19 vaccination intent in European young adults.
    PLoS One. 2024;19:e0300814.
    >> Share

  288. UMER BA, Noyce RS, Kieser Q, Favis NA, et al
    Oncolytic vaccinia virus immunotherapy antagonizes image-guided radiotherapy in mouse mammary tumor models.
    PLoS One. 2024;19:e0298437.
    >> Share

  289. STOSIC M, Plavsa D, Jovanovic V, Veljkovic M, et al
    Factors associated with COVID-19 among hospitalized patients with severe acute respiratory infections in Serbia, 2022-2023: A test negative case-control study.
    PLoS One. 2024;19:e0299210.
    >> Share

  290. WALSH-BUHI ML, Houghton RF, Valdez D, Walsh-Buhi ER, et al
    A theory-based assessment of mpox: Findings from a nationally representative survey of U.S. adults.
    PLoS One. 2024;19:e0299599.
    >> Share

  291. LEE KS, Go MJ, Choi YY, Kim MK, et al
    Risk factors for critical COVID-19 illness during Delta- and Omicron-predominant period in Korea; using K-COV-N cohort in the National health insurance service.
    PLoS One. 2024;19:e0300306.
    >> Share

  292. AZAMAR-LLAMAS D, Arenas-Martinez JS, Olivas-Martinez A, Jimenez JV, et al
    Impact of COVID-19 vaccination on liver transplant recipients. Experience in a reference center in Mexico.
    PLoS One. 2024;19:e0301198.
    >> Share

  293. BRAY LA, Jervis LL, Janitz AE, Ross L, et al
    Toward trustworthy COVID-19 interventions: Building vaccine trust through community-university partnerships.
    PLoS One. 2024;19:e0300872.
    >> Share

  294. DIMNJAKOVIC J, Buble T, Ivanko P, Poljicanin T, et al
    Association of anti-diabetic drugs and covid-19 outcomes in patients with diabetes mellitus type 2 and chronic kidney disease: Nationwide registry analysis.
    PLoS One. 2024;19:e0301056.
    >> Share

  295. PAUDEL S, Apostolakos I, Vougat Ngom R, Tilli G, et al
    A systematic review and meta-analysis on the efficacy of vaccination against colibacillosis in broiler production.
    PLoS One. 2024;19:e0301029.
    >> Share

  296. THERESA POOL SN, Shroff EH, Chetty A, Lewis L, et al
    Effectiveness of ChAdOx1 nCoV-19 and BBIBP-CorV vaccines against COVID-19-associated hospitalisation and death in the Seychelles infected adult population.
    PLoS One. 2024;19:e0299747.
    >> Share

  297. AGIMAS MC, Belew AK, Sisay M, Daniel Baffa L, et al
    Spatial variations and determinants of timely completion of vaccination in Ethiopia using further analysis of EDHS 2019 data: Spatial and multilevel analysis.
    PLoS One. 2024;19:e0301409.
    >> Share

  298. FISMAN DN, Amoako A, Simmons A, Tuite AR, et al
    Impact of immune evasion, waning and boosting on dynamics of population mixing between a vaccinated majority and unvaccinated minority.
    PLoS One. 2024;19:e0297093.
    >> Share

  299. SILVA LA, Souza MF, Carvalho TP, Santana CH, et al
    Comparative study on alginate/chitosan microcapsules and Montanide ISA 61 as vaccine adjuvants in mice.
    PLoS One. 2024;19:e0298117.
    >> Share

  300. HERNANDEZ-BELLO J, Lorenzo-Leal AC, Munoz-Valle JF, Morales-Nunez JJ, et al
    Neutralizing antibody responses to the Delta variant of SARS-CoV-2 following vaccination with Ad5-nCoV (CanSino) in the Mexican population.
    PLoS One. 2024;19:e0299520.
    >> Share

  301. MWANGI LW, Omuse G, Adam R, Ong'ete G, et al
    Post-vaccination SARS-CoV-2 IgG spike antibody responses among clinical and non-clinical healthcare workers at a tertiary facility in Kenya.
    PLoS One. 2024;19:e0299302.
    >> Share

  302. ECHEVERRI TRIBIN F, Williams E, Testamarck V, Carreno JM, et al
    Determinants of health as predictors for differential antibody responses following SARS-CoV-2 primary and booster vaccination in an at-risk, longitudinal cohort.
    PLoS One. 2024;19:e0292566.
    >> Share

  303. RICCI CONESA H, Skroder H, Norton N, Bencina G, et al
    Clinical and economic burden of acute otitis media caused by Streptococcus pneumoniae in European children, after widespread use of PCVs-A systematic literature review of published evidence.
    PLoS One. 2024;19:e0297098.
    >> Share

  304. THANGARAJ JWV, Prosperi C, Kumar MS, Hasan AZ, et al
    Post-campaign coverage evaluation of a measles and rubella supplementary immunization activity in five districts in India, 2019-2020.
    PLoS One. 2024;19:e0297385.
    >> Share

  305. ALAMARES-SAPUAY J, Kishko M, Lai C, Parrington M, et al
    Mutations in the F protein of the live-attenuated respiratory syncytial virus vaccine candidate DeltaNS2/Delta1313/I1314L increase the stability of infectivity and content of prefusion F protein.
    PLoS One. 2024;19:e0301773.
    >> Share

  306. UNFRIED K, Priebe J
    Who shares fake news on social media? Evidence from vaccines and infertility claims in sub-Saharan Africa.
    PLoS One. 2024;19:e0301818.
    >> Share

  307. RAZAI MS, Mansour R, Ravindran P, Freeman S, et al
    Facilitators and barriers to vaccination uptake in pregnancy: A qualitative systematic review.
    PLoS One. 2024;19:e0298407.
    >> Share

  308. HOSSAIN FB, Jayasinghe S, Blazek K, He WQ, et al
    Pneumococcal vaccination and primary care presentations for acute respiratory tract infection and antibiotic prescribing in older adults.
    PLoS One. 2024;19:e0299924.
    >> Share

  309. ZHANG Q, Tiwari S, Wen J, Wang S, et al
    Induction of neutralizing antibodies against SARS-CoV-2 variants by a multivalent mRNA-lipid nanoparticle vaccine encoding SARS-CoV-2/SARS-CoV Spike protein receptor-binding domains in mice.
    PLoS One. 2024;19:e0300524.
    >> Share

  310. RENEER ZB, Bergeron HC, Reynolds S, Thornhill-Wadolowski E, et al
    mRNA vaccines encoding influenza virus hemagglutinin (HA) elicits immunity in mice from influenza A virus challenge.
    PLoS One. 2024;19:e0297833.
    >> Share

  311. BADE V, Schmitz H, Tawiah BB
    Regional variations in vaccination against COVID-19 in Germany.
    PLoS One. 2024;19:e0296976.
    >> Share

  312. SANVEE-BLEBO LM, Adewuyi PA, Whesseh FK, Babalola OJ, et al
    COVID-19 vaccine hesitancy among adults in Liberia, April-May 2021.
    PLoS One. 2024;19:e0297089.
    >> Share

  313. ZAID SNA, Abdul Kadir A, Mohd Noor N, Ahmad B, et al
    Translation and trans-cultural adaptation to the Malay version of the COVID-19 vaccine hesitancy questionnaire among healthcare workers in Malaysia.
    PLoS One. 2024;19:e0302237.
    >> Share

  314. LERDSAMRAN H, Anusorntanawat R, Sangsiriwut K, Sawadpongpan S, et al
    Higher correlation between neutralizing antibodies and surrogate neutralizing or binding antibodies in COVID-19 patients than vaccine recipients.
    PLoS One. 2024;19:e0298033.
    >> Share

  315. TAN H, Liu J, Zhang Y
    Effects of COVID-19 vaccine safety framing on parental reactions.
    PLoS One. 2024;19:e0302233.
    >> Share

  316. MARQUEZ-MARTINEZ S, Salisch N, Serroyen J, Zahn R, et al
    Peak transgene expression after intramuscular immunization of mice with adenovirus 26-based vector vaccines correlates with transgene-specific adaptive immune responses.
    PLoS One. 2024;19:e0299215.
    >> Share

  317. THIELMANN A, Schmitz MT, Welchowski T, Weltermann B, et al
    Effectiveness of the online-eLearning program KeepCoool at improving the vaccine cold chain in general practices.
    PLoS One. 2024;19:e0301847.
    >> Share

  318. KYAKUWA N, Kimbugwe G, Nakanjako F, Kalute H, et al
    High uptake of COVID-19 vaccines among healthcare workers in urban Uganda.
    PLoS One. 2024;19:e0277072.
    >> Share

  319. LIN L, Demirhan H, P Johnstone-Robertson S, Lal R, et al
    Assessing the impact of Australia's mass vaccination campaigns over the Delta and Omicron outbreaks.
    PLoS One. 2024;19:e0299844.
    >> Share

  320. SENOO-DOGBEY VE, Anto F, Quansah R, Danso-Appiah A, et al
    Completion of three-dose hepatitis B vaccination cycle and associated factors among health care workers in the Greater Accra Region of Ghana.
    PLoS One. 2024;19:e0298771.
    >> Share

  321. O'KENNEDY MM, Roth R, Ebersohn K, du Plessis LH, et al
    Immunogenic profile of a plant-produced nonavalent African horse sickness viral protein 2 (VP2) vaccine in IFNAR-/- mice.
    PLoS One. 2024;19:e0301340.
    >> Share

  322. CHISTY ZA, Li DD, Haile M, Houston H, et al
    Immune response kinetics to SARS-CoV-2 infection and COVID-19 vaccination among nursing home residents-Georgia, October 2020-July 2022.
    PLoS One. 2024;19:e0301367.
    >> Share

  323. COGILL S, Nallamshetty S, Fullenkamp N, Heberer K, et al
    Predicting clinical outcomes of SARS-CoV-2 infection during the Omicron wave using machine learning.
    PLoS One. 2024;19:e0290221.
    >> Share

  324. FANG F, Clemens JD, Zhang ZF, Brewer TF, et al
    Impact of SARS-CoV-2 vaccines on Covid-19 incidence and mortality in the United States.
    PLoS One. 2024;19:e0301830.
    >> Share

  325. KHAMI MR, Karimi M, Folayan MO, Shamshiri AR, et al
    Patients' knowledge about dental emergencies, COVID-19 transmission, and required preparations in dental settings.
    PLoS One. 2024;19:e0301460.
    >> Share

  326. KASSA ZY, Scarf V, Turkmani S, Fox D, et al
    Impact of COVID-19 on antenatal care provision at public hospitals in the Sidama region, Ethiopia: A mixed methods study.
    PLoS One. 2024;19:e0301994.
    >> Share

  327. RAZAFINDRAKOTO M, Roubaud F, Castilho MR, Pero V, et al
    Investigating the 'Bolsonaro effect' on the spread of the Covid-19 pandemic: An empirical analysis of observational data in Brazil.
    PLoS One. 2024;19:e0288894.
    >> Share

  328. TAMARGO JA, Martin HR, Diaz-Martinez J, Delgado-Enciso I, et al
    Drug use and COVID-19 testing, vaccination, and infection among underserved, minority communities in Miami, Florida.
    PLoS One. 2024;19:e0297327.
    >> Share

  329. YAMAJI T, Harada T, Hashimoto Y, Nakano Y, et al
    Effects of BNT162b2 mRNA Covid-19 vaccine on vascular function.
    PLoS One. 2024;19:e0302512.
    >> Share

  330. HWANG LA, Vaithilingam S, Ng JWJ, Nair M, et al
    The continuance intention to vaccinate against COVID-19: An empirical study from Malaysia.
    PLoS One. 2024;19:e0301383.
    >> Share

  331. JANNAT Z, Das H, Ali MW, Wahed T, et al
    Disparities in COVID-19 vaccine uptake among rural hard-to-reach population and urban high-risk groups of Bangladesh.
    PLoS One. 2024;19:e0302056.
    >> Share

  332. JOHN FA, Criollo V, Gaghan C, Armwood A, et al
    Immunization of turkeys with Clostridium septicum alpha toxin-based recombinant subunit proteins can confer protection against experimental Clostridial dermatitis.
    PLoS One. 2024;19:e0302555.
    >> Share

  333. CHENG MC, Lai GH, Tsai YL, Lien YY, et al
    Circulating hypervirulent Marek's disease viruses in vaccinated chicken flocks in Taiwan by genetic analysis of meq oncogene.
    PLoS One. 2024;19:e0303371.
    >> Share

  334. KUMAR A, Misra G, Mohandas S, Yadav PD, et al
    Multi-epitope vaccine design using in silico analysis of glycoprotein and nucleocapsid of NIPAH virus.
    PLoS One. 2024;19:e0300507.
    >> Share

  335. RAMOS A, Martins S, Marinho AS, Norton P, et al
    Evaluation of SARS-CoV-2 interferon gamma release assay in BNT162b2 vaccinated healthcare workers.
    PLoS One. 2024;19:e0303244.
    >> Share

  336. CHOI Y, Kim IK, Kim SJ, Kim HS, et al
    Predictors of positive tuberculin skin test in neonates exposed to pulmonary tuberculosis.
    PLoS One. 2024;19:e0303050.
    >> Share

  337. RAJOROMANANA B, Nyirenda G, Edosoa GT, Andrianasolo RL, et al
    Dog ecology and rabies control including canine vaccination coverage: Impacts from a survey in Madagascar.
    PLoS One. 2024;19:e0302690.
    >> Share

  338. BURUSIE A, Enquesilassie F, Salazar-Austin N, Addissie A, et al
    Determinants of tuberculosis disease development in children in central Ethiopia: A matched case-control study.
    PLoS One. 2024;19:e0300731.
    >> Share

  339. NOUR D, Ismail MB, Osman M, Rafei R, et al
    Evaluation of SARS-CoV-2 anti-Spike antibody levels and breakthrough infection risk among vaccinated adults in North Lebanon.
    PLoS One. 2024;19:e0302579.
    >> Share

  340. AGGARWAL S, Singh L, Alam U, Sharma S, et al
    COVID-19 vaccine hesitancy among adults in India: A primary study based on health behavior theories and 5C psychological antecedents model.
    PLoS One. 2024;19:e0294480.
    >> Share

  341. OMALE UI, Ikegwuonu CO, Nkwo GE, Nwali UIA, et al
    COVID-19 and COVID-19 vaccination experiences and perceptions among health workers during the pandemic in Ebonyi state, Nigeria: An analytical cross-sectional study.
    PLoS One. 2024;19:e0303172.
    >> Share

  342. VAMEGHI M, Saatchi M, Bahrami G, Soleimani F, et al
    How did we protect children against COVID-19 in Iran? Prevalence of COVID-19 and vaccination in the socio-economic context of COVID-19 epidemic.
    PLoS One. 2024;19:e0303043.
    >> Share

  343. IQBAL NT, Ahmed K, Sattar T, Aziz F, et al
    BCG activation of trained immunity is associated with induction of cross reactive COVID-19 antibodies in a BCG vaccinated population.
    PLoS One. 2024;19:e0302722.
    >> Share


  344. Retraction: Enhanced Immune Response and Protective Effects of Nano-chitosan-based DNA Vaccine Encoding T Cell Epitopes of Esat-6 and FL against Mycobacterium Tuberculosis Infection.
    PLoS One. 2024;19:e0303549.
    >> Share

  345. WHELAN AO, Flick-Smith HC, Walker NJ, Abraham A, et al
    A glucan-particle based tularemia subunit vaccine induces T-cell immunity and affords partial protection in an inhalation rat infection model.
    PLoS One. 2024;19:e0294998.
    >> Share

  346. KIM S, Lilani A, Redemptus C, Campana K, et al
    A pre-post evaluation study of a social media-based COVID-19 communication campaign to improve attitudes and behaviors toward COVID-19 vaccination in Tanzania.
    PLoS One. 2024;19:e0300206.
    >> Share

  347. MOIN AT, Rani NA, Patil RB, Robin TB, et al
    In-silico formulation of a next-generation polyvalent vaccine against multiple strains of monkeypox virus and other related poxviruses.
    PLoS One. 2024;19:e0300778.
    >> Share

  348. URAZAYEVA ST, Kurmangaliyeva SS, Kaliyev AA, Tussupkaliyeva KS, et al
    Attitude toward vaccination against COVID-19 and acceptance of the national "QazVac" vaccine in the Aktobe city population, West Kazakhstan: A cross-sectional survey.
    PLoS One. 2024;19:e0303854.
    >> Share

  349. KHEZRI M, McKnight C, Weng CA, Kimball S, et al
    COVID-19 vaccination uptake and determinants of booster vaccination among persons who inject drugs in New York City.
    PLoS One. 2024;19:e0303394.
    >> Share

  350. WASSIE GT, Ambelie YA, Adebabay T, Yeshiwas AG, et al
    Covid-19 vaccine uptake and its associated factors among adult population in Dangila district, Awi Zone, Northwest Ethiopia: A mixed method study.
    PLoS One. 2024;19:e0302531.
    >> Share

  351. YASEEN A, DeSantis SM, Sabharwal R, Talebi Y, et al
    Baseline characteristics of SARS-CoV-2 vaccine non-responders in a large population-based sample.
    PLoS One. 2024;19:e0303420.
    >> Share

  352. GICHUKI J, Ngoye B, Wafula F
    "I'll take them another day": A qualitative study exploring the socio-behavioral complexities of childhood vaccination in urban poor settlements.
    PLoS One. 2024;19:e0303215.
    >> Share

  353. HURST JH, Shaik-Dasthagirisaheb YB, Truong L, Boiditswe SC, et al
    Serotype epidemiology and antibiotic resistance of pneumococcal isolates colonizing infants in Botswana (2016-2019).
    PLoS One. 2024;19:e0302400.
    >> Share

  354. BROSHKEVITCH CJ, Barnabas RV, Liu G, Palanee-Phillips T, et al
    Enhanced cervical cancer and HIV interventions reduce the disproportionate burden of cervical cancer cases among women living with HIV: A modeling analysis.
    PLoS One. 2024;19:e0301997.
    >> Share

  355. COBB J, Rawson J, Gonzalez N, Orr C, et al
    Reversal of diabetes by an oral Salmonella-based vaccine in acute and progressive diabetes in NOD mice.
    PLoS One. 2024;19:e0303863.
    >> Share

  356. KASZTELEWICZ B, Skrok K, Burzynska J, Migdal M, et al
    Incidence of SARS-CoV-2 infection among healthcare workers before and after COVID-19 vaccination in a tertiary paediatric hospital in Warsaw: A retrospective cohort study.
    PLoS One. 2024;19:e0301612.
    >> Share

  357. TRZEBINSKI W, Trzebinski J
    Correction: How does collectivism help deal with perceived vaccine artificiality? The case of COVID-19 vaccination intent in European young adults.
    PLoS One. 2024;19:e0304372.
    >> Share

  358. LOPEZ-CODONY V, de Andres-Pablo A, Ferrando-Diez A, Fernandez-Montoli ME, et al
    Assessing the reduction of viral infectivity in HPV16/18-positive women after one, two, and three doses of Gardasil-9 (RIFT): Study protocol.
    PLoS One. 2024;19:e0304080.
    >> Share

  359. YOSHIMURA M, Honda Y, Yonemitsu E, Kuraoka K, et al
    Method for quantifying the Pasteurella multocida antigen adsorbed on aluminum hydroxide adjuvant in swine atrophic rhinitis vaccine.
    PLoS One. 2024;19:e0301688.
    >> Share

  360. LIU Y, Zhang C, Wang Y, Luo X, et al
    Seroepidemiology of pertussis in Huzhou: A population-based, cross-sectional study.
    PLoS One. 2024;19:e0303508.
    >> Share

  361. BRIZUELA M, Palermo MC, Alconada T, Sandoval MM, et al
    Nasopharyngeal carriage of Streptococcus pneumoniae in Latin America and the Caribbean: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0297767.
    >> Share

  362. TAMIR TT, Workneh BS, Mekonen EG, Zegeye AF, et al
    Coverage, spatial distribution and determinants of childhood inactivated poliovirus vaccine immunization in Ethiopia.
    PLoS One. 2024;19:e0301933.
    >> Share

  363. HUSSEIN K, Kokwaro G, Wafula F, Kassie GM, et al
    Assessing the influence of the health system on access to cervical cancer prevention, screening, and treatment services at public health centers in Addis Ababa, Ethiopia.
    PLoS One. 2024;19:e0300152.
    >> Share

  364. ARBEL Y, Arbel Y, Kerner A, Kerner M, et al
    Can COVID-19 herd immunity be achieved at a city level?
    PLoS One. 2024;19:e0299574.
    >> Share

  365. MERAYA AM, Syed MH, Shabi AA, Madkhali HA, et al
    Assessment of community pharmacists' knowledge, attitudes and their willingness to provide vaccination services in Saudi Arabia.
    PLoS One. 2024;19:e0304287.
    >> Share

  366. LE T, Flores M, Omaleki V, Hassani A, et al
    Assessing the impact of institutional mistrust on parental endorsement for COVID-19 vaccination among school communities in San Diego County, California.
    PLoS One. 2024;19:e0295618.
    >> Share

  367. GARG N, Tellier G, Vale N, Kluge J, et al
    Phase 1, randomized, rater and participant blinded placebo-controlled study of the safety, reactogenicity, tolerability and immunogenicity of H1N1 influenza vaccine delivered by VX-103 (a MIMIX microneedle patch [MAP] system) in healthy adults.
    PLoS One. 2024;19:e0303450.
    >> Share

  368. ARTEMCHUK O, Evlampidou I
    Knowledge, attitudes and practices survey towards pneumococcal infection and vaccination among primary health care physicians, Ukraine, 2021.
    PLoS One. 2024;19:e0304346.
    >> Share

  369. SASSE K, Mahabir R, Gkountouna O, Crooks A, et al
    Understanding the determinants of vaccine hesitancy in the United States: A comparison of social surveys and social media.
    PLoS One. 2024;19:e0301488.
    >> Share

  370. RIBEIRO LB, Gazzinelli A, Santiago HDC, Fiuza JA, et al
    Public engagement for the conduct of a controlled human infection study testing vaccines against Necator americanus (hookworm) in areas of active hookworm transmission in Brazil.
    PLoS One. 2024;19:e0299022.
    >> Share

  371. CHEN LP, Singh-Verdeflor K, Kelly MM, Sklansky DJ, et al
    Disparities in COVID-19 vaccine intentions, testing and trusted sources by household language for children with medical complexity.
    PLoS One. 2024;19:e0305553.
    >> Share

  372. CHICOINE N, Schnipper N, Griffin J
    The role of hesitancy and infrastructure in the equity and efficiency of COVID-19 vaccine administration.
    PLoS One. 2024;19:e0304416.
    >> Share

  373. BREWER SE, Bertin KB, Suresh K, LoudHawk-Hedgepeth C, et al
    Factors in COVID-19 vaccine uptake in five racial/ethnic Colorado communities: A report from the Colorado CEAL project.
    PLoS One. 2024;19:e0305160.
    >> Share

  374. CHEN F, Nakanishi H, Sekizawa Y, Ochi S, et al
    Investigating the causal effects of COVID-19 vaccination on the adoption of protective behaviors in Japan: Insights from a fuzzy regression discontinuity design.
    PLoS One. 2024;19:e0305043.
    >> Share

  375. DALKY A, Quran TO, Abuhammad S, Al-Faraj HM, et al
    COVID-19 vaccine acceptance and associated factors among pregnant and lactating women attending maternity care clinics in refugee camps in Jordan.
    PLoS One. 2024;19:e0305314.
    >> Share

  376. ASHCROFT R, Donnelly C, Sheffield P, Lam S, et al
    A qualitative examination of the experiences and perspectives of interprofessional primary health care teams in the distribution of the COVID-19 vaccination in Ontario, Canada.
    PLoS One. 2024;19:e0304616.
    >> Share

  377. CHIEN LC, Marquez ER, Smith S, Tu T, et al
    Exploring the role of the social vulnerability index in understanding COVID-19 immunization rates.
    PLoS One. 2024;19:e0302934.
    >> Share

  378. CHERVO TC, Elkin EP, Nugent JR, Valice E, et al
    Relative contribution of COVID-19 vaccination and SARS-CoV-2 infection to population-level seroprevalence of SARS-CoV-2 spike antibodies in a large integrated health system.
    PLoS One. 2024;19:e0303303.
    >> Share

  379. GURAV YK, Bagepally BS, Chitpim N, Sobhonslidsuk A, et al
    Cost-effective analysis of hepatitis A vaccination in Kerala state, India.
    PLoS One. 2024;19:e0306293.
    >> Share

  380. FARHAN M, Shah Z, Ling Z, Shah K, et al
    Global dynamics and computational modeling for analyzing and controlling Hepatitis B: A novel epidemic approach.
    PLoS One. 2024;19:e0304375.
    >> Share

  381. BARDACH A, Ruvinsky S, Palermo MC, Alconada T, et al
    Invasive pneumococcal disease in Latin America and the Caribbean: Serotype distribution, disease burden, and impact of vaccination. A systematic review and meta-analysis.
    PLoS One. 2024;19:e0304978.
    >> Share

  382. SAMMAN N, Mohabatkar H, Behbahani M, Ganjlikhani Hakemi M, et al
    Bioinformatics design of a peptide vaccine containing sarcoma antigen NY-SAR-35 epitopes against breast cancer and evaluation of its immunological function in BALB/c mouse model.
    PLoS One. 2024;19:e0306117.
    >> Share

  383. NONBOE MH, Napolitano GM, Kann C, Andersen B, et al
    Screening outcome of HPV-vaccinated women: Data from the Danish Trial23 cohort study.
    PLoS One. 2024;19:e0306044.
    >> Share

  384. DEBELLUT F, Friedrich A, Baral R, Pecenka C, et al
    The cost of typhoid illness in low- and middle-income countries, a scoping review of the literature.
    PLoS One. 2024;19:e0305692.
    >> Share

  385. WERDIN S, Neufeind J
    The implementation of a new measles vaccine mandate in Germany: A qualitative study in local health departments.
    PLoS One. 2024;19:e0306003.
    >> Share

  386. BOTELHO RO, Coelho CCF, Andrade EF, Castelo PM, et al
    Fear of the COVID-19 vaccine in a public healthcare system and university setting.
    PLoS One. 2024;19:e0304000.
    >> Share

  387. CARLOCK MA, Allen JD, Hanley HB, Ross TM, et al
    Longitudinal assessment of human antibody binding to hemagglutinin elicited by split-inactivated influenza vaccination over six consecutive seasons.
    PLoS One. 2024;19:e0301157.
    >> Share

  388. AKRONG GB, Hiadzi RA, Donkor AB, Anafo DK, et al
    COVID-19 vaccine acceptance and hesitancy in Ghana: A systematic review.
    PLoS One. 2024;19:e0305993.
    >> Share

  389. YU H, Bonett S, Oyiborhoro U, Aryal S, et al
    Psychosocial correlates of parents' willingness to vaccinate their children against COVID-19.
    PLoS One. 2024;19:e0305877.
    >> Share

  390. FERRIS BF, Balasubramanian S, Rajamanickam A, Munisankar S, et al
    Relative contribution of biomedical, demographic, and socioeconomic factors to COVID-19 vaccine receipt in rural India.
    PLoS One. 2024;19:e0305819.
    >> Share

  391. YAZDANI Y, Pai P, Sayfi S, Mohammadi A, et al
    Predictors of COVID-19 vaccine acceptability among refugees and other migrant populations: A systematic scoping review.
    PLoS One. 2024;19:e0292143.
    >> Share

  392. SMITH DG, Smith CD, DeLeon JA, Sandoz JL, et al
    Factors influencing COVID-19 vaccine uptake among Latinos: A cross-sectional study.
    PLoS One. 2024;19:e0302332.
    >> Share

  393. BHATTACHARJEE A, Hosen MR, Lamisa AB, Ahammad I, et al
    An integrated comparative genomics, subtractive proteomics and immunoinformatics framework for the rational design of a Pan-Salmonella multi-epitope vaccine.
    PLoS One. 2024;19:e0292413.
    >> Share

  394. RAJI T, Fallah MP, Dereje N, Kakooza F, et al
    Efficacy and effectiveness of COVID-19 vaccines in Africa: A systematic review.
    PLoS One. 2024;19:e0306309.
    >> Share

  395. MAHARLOUEI N, Hosseinpour P, Erfani A, Shahriarirad R, et al
    Correction: Factors associated with reluctancy to acquire COVID-19 vaccination: A cross-sectional study in Shiraz, Iran, 2022.
    PLoS One. 2024;19:e0307336.
    >> Share

  396. TAREKE AA, Tewabe Ayelign A, Yewodiaw TK, Shiferaw EW, et al
    Retention rate of vaccination card and its associated factors among vaccinated children aged 12 horizontal line 23 months in Ethiopia: Multilevel logistic regression analysis.
    PLoS One. 2024;19:e0306421.
    >> Share

  397. AL-RASHDAN RA, Ta'an W, Mukattash T, Williams B, et al
    Maternal skepticism regarding children's vaccination in Jordan: Investigating the knowledge, attitude, and adherence.
    PLoS One. 2024;19:e0305209.
    >> Share

  398. MASUM MHU, Wajed S, Hossain MI, Moumi NR, et al
    An mRNA vaccine for pancreatic cancer designed by applying in silico immunoinformatics and reverse vaccinology approaches.
    PLoS One. 2024;19:e0305413.
    >> Share

  399. OLANI KUTA A, Dida N
    Covid-19 vaccine hesitancy and its predictors among diabetic patients on follow-up at public hospitals in Nekemte Town, Western Ethiopia.
    PLoS One. 2024;19:e0305200.
    >> Share

  400. ZEGEYE AF, Mekonen EG, Tekeba B, Alemu TG, et al
    Spatial distribution and determinants of measles vaccination dropout among under-five children in Ethiopia: A spatial and multilevel analysis of 2019 Ethiopian demographic and health survey.
    PLoS One. 2024;19:e0305393.
    >> Share

  401. SALAZAR JC, Vargas-Cely F, Garcia-Luna JA, Ramirez LG, et al
    Treponema pallidum genetic diversity and its implications for targeted vaccine development: A cross-sectional study of early syphilis cases in Southwestern Colombia.
    PLoS One. 2024;19:e0307600.
    >> Share

  402. ZEHRA A, Jamil S, Farman M, Nisar KS, et al
    Modeling and analysis of Hepatitis B dynamics with vaccination and treatment with novel fractional derivative.
    PLoS One. 2024;19:e0307388.
    >> Share

  403. MANSOUR AA, Hussein SM, Felemban SG, Mahamid AW, et al
    Correction: Acceptance and hesitancy of parents to vaccinate children against coronavirus disease 2019 in Saudi Arabia.
    PLoS One. 2024;19:e0307674.
    >> Share

  404. QUEE FA, Hogema BM, Molier M, Slot E, et al
    The Elecsys(R) Anti-SARS-CoV-2 and Elecsys(R) Anti-SARS-CoV-2 S antibody assays: Differentiating between vaccination and infection, and assessing long-term performance.
    PLoS One. 2024;19:e0305613.
    >> Share

  405. HOY C, Wood T, Moscoe E
    Correction: Addressing vaccine hesitancy in developing countries: Survey and experimental evidence.
    PLoS One. 2024;19:e0307570.
    >> Share


  406. Retraction: Entrapment of H1N1 Influenza Virus Derived Conserved Peptides in PLGA Nanoparticles Enhances T Cell Response and Vaccine Efficacy in Pigs.
    PLoS One. 2024;19:e0307483.
    >> Share

  407. NOURANI L, Mehrizi AA, Zakeri S, Djadid ND, et al
    Correction: Untangling population structure and genetic diversity of reticulocyte binding protein 2b (PvRBP2b) erythrocytic stage vaccine candidate in worldwide Plasmodium vivax isolates.
    PLoS One. 2024;19:e0307447.
    >> Share

  408. LEE J, Lee CW, Suarez DL, Lee SA, et al
    Efficacy of commercial recombinant HVT vaccines against a North American clade 2.3.4.4b H5N1 highly pathogenic avian influenza virus in chickens.
    PLoS One. 2024;19:e0307100.
    >> Share

  409. VAN DEN BOSSCHE J, De Laere M, Deschepper K, Germonpre P, et al
    Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma-Protocol of the Immuno-MESODEC study.
    PLoS One. 2024;19:e0307204.
    >> Share

  410. BALQIS-ALI NZ, Anis-Syakira J, Fun WH, Mohd Said Z, et al
    Achieving cervical cancer elimination: The simulated impacts of HPV vaccination and transitioning from liquid-based cytology to HPV-based screening test.
    PLoS One. 2024;19:e0307880.
    >> Share

  411. BINDER RA, Matta AM, Forconi CS, Oduor CI, et al
    Minding the margins: Evaluating the impact of COVID-19 among Latinx and Black communities with optimal qualitative serological assessment tools.
    PLoS One. 2024;19:e0307568.
    >> Share

  412. TREGNAGO D, Avancini A, Belluomini L, Trestini I, et al
    Correction: Cross-sectional survey evaluating the psychological impact of the COVID-19 vaccination campaign in patients with cancer: The VACCINATE study.
    PLoS One. 2024;19:e0307924.
    >> Share

  413. RASHITI-BYTYCI A, White Johansson E, Kacaniku-Gunga P, Danis K, et al
    Estimation of COVID-19 vaccine effectiveness against infections and severe outcomes using routine surveillance data in Kosovo, July-September 2021.
    PLoS One. 2024;19:e0305629.
    >> Share

  414. RIEDMILLER I, Fougeroux C, Jensen RW, Kana IH, et al
    Mosaic and cocktail capsid-virus-like particle vaccines for induction of antibodies against the EPCR-binding CIDRalpha1 domain of PfEMP1.
    PLoS One. 2024;19:e0302243.
    >> Share

  415. MANTINA NM, Ngaybe MGB, Zeiders KH, Osman KM, et al
    Latinx youth's and parents' covid-19 beliefs, vaccine hesitancy and vaccination rates: Longitudinal associations in a community sample.
    PLoS One. 2024;19:e0307479.
    >> Share

  416. ALI L, Rauf S, Khan A, Rasool S, et al
    In silico design of multi-epitope vaccines against the hantaviruses by integrated structural vaccinology and molecular modeling approaches.
    PLoS One. 2024;19:e0305417.
    >> Share

  417. GONZALEZ-BLOCK MA, Gutierrez-Calderon E, Pelcastre-Villafuerte BE, Arroyo-Laguna J, et al
    Correction: Influenza vaccination hesitancy in five countries of South America. Confidence, complacency and convenience as determinants of immunization rates.
    PLoS One. 2024;19:e0308524.
    >> Share

  418. OGOLLA KO, Anyona DN, Chemuliti JK, Kimani WW, et al
    Effectiveness of a community-centered Newcastle disease vaccine delivery model under paid and free vaccination frameworks in southeastern Kenya.
    PLoS One. 2024;19:e0308088.
    >> Share

  419. FUKUI S
    Unravelling habituation for COVID-19-related information: A panel data study in Japan.
    PLoS One. 2024;19:e0306456.
    >> Share

  420. THOMPSON O, Cristea M, Tamariz M
    COVID-19 vaccination attitudes and uptake: A sociocultural perspective focusing on parents and peers.
    PLoS One. 2024;19:e0300771.
    >> Share

  421. MAKI KO, Karlsson LC, Kaakinen JK, Schmid P, et al
    COVID-19 and influenza vaccine-hesitancy subgroups.
    PLoS One. 2024;19:e0308159.
    >> Share

  422. SERWANGA J, Oluka GK, Baine C, Ankunda V, et al
    Persistent and robust antibody responses to ChAdOx1-S Oxford-AstraZeneca (ChAdOx1-S, Covishield) SARS-CoV-2 vaccine observed in Ugandans across varied baseline immune profiles.
    PLoS One. 2024;19:e0303113.
    >> Share

  423. FOPPIANI A, Montanari C, Zanelli S, Lombardo MDM, et al
    Long-COVID symptom monitoring: Insights from a two-year telemedicine study.
    PLoS One. 2024;19:e0307834.
    >> Share

  424. SANDBORN H, Delamater P, Brewer NT, Gilkey MB, et al
    The geography of COVID-19 vaccine completion by age in North Carolina, U.S.
    PLoS One. 2024;19:e0304812.
    >> Share

  425. RUDOLPH L, Koubi V, Freihardt J
    COVID-19 vaccination uptake in remote areas-Evidence from a panel survey in Bangladesh.
    PLoS One. 2024;19:e0305659.
    >> Share

  426. NAKIBUUKA V, Muddu M, Kraehenbuhl JP, Birungi C, et al
    Uptake of human papilloma virus vaccination among adolescent girls living with HIV in Uganda: A mixed methods study.
    PLoS One. 2024;19:e0300155.
    >> Share

  427. MORENO ECHEVARRIA F, Caputo M, Camp D, Reddy S, et al
    Incidence and risk factors of SARS-CoV-2 breakthrough infection in the early Omicron variant era among vaccinated and boosted individuals in Chicago.
    PLoS One. 2024;19:e0302338.
    >> Share

  428. ARSHAD NF, Nordin FJ, Foong LC, In LLA, et al
    Engineering receptor-binding domain and heptad repeat domains towards the development of multi-epitopes oral vaccines against SARS-CoV-2 variants.
    PLoS One. 2024;19:e0306111.
    >> Share

  429. SKIRROW H, Lewis C, Haque H, Choundary-Salter L, et al
    The impact of the COVID-19 pandemic on UK parents' attitudes towards routine childhood vaccines: A mixed-methods study.
    PLoS One. 2024;19:e0306484.
    >> Share

  430. EZEZIKA O, Adedugbe T, Jonas I, Mengistu M, et al
    Resilience throughout COVID-19: Unmasking the realities of COVID-19 and vaccination facilitators, barriers, and attitudes among Black Canadians.
    PLoS One. 2024;19:e0304904.
    >> Share

  431. JIANG H, Zhang C, Meng X, Chi S, et al
    COVID-19, vaccination and migraine: Causal association or epiphenomenon?
    PLoS One. 2024;19:e0308151.
    >> Share

  432. WRIGHT J, Crowcroft N, McLachlan E, Perez-Iratxeta C, et al
    Population immunity to varicella in Canada: A Canadian Immunization Research Network (CIRN) study.
    PLoS One. 2024;19:e0309154.
    >> Share

  433. GIDADO S, Musa M, Ba'aba AI, Okeke LA, et al
    COVID-19 vaccination intention among internally displaced persons in complex humanitarian emergency context, Northeast Nigeria.
    PLoS One. 2024;19:e0308139.
    >> Share

  434. GAULD NJ, Knapton C, Sinclair O, Grant CC, et al
    Promotion and COVID-19 lockdown increase uptake of funded maternal pertussis vaccination in pharmacy: A mixed methods study.
    PLoS One. 2024;19:e0307971.
    >> Share

  435. KISA S, Kisa A
    Religious beliefs and practices toward HPV vaccine acceptance in Islamic countries: A scoping review.
    PLoS One. 2024;19:e0309597.
    >> Share

  436. LEON-ROJAS JE, Arias-Erazo F, Jimenez-Arias P, Recalde-Navarrete R, et al
    COVID-19 IgG seropositivity and its determinants in occupational groups of varying infection risks in two Andean cities of Ecuador before mass vaccination.
    PLoS One. 2024;19:e0309466.
    >> Share

  437. BERROU I, Hobbs L, Jones S, Hughes S, et al
    Lessons learnt from the implementation of the Covid-19 vaccination programme in the Southwest of England.
    PLoS One. 2024;19:e0309230.
    >> Share

  438. BARQAWI HJ, Samara KA, Kannas SM, Habbal O, et al
    Vaccine practices, literacy, and hesitancy among parents in the United Arab Emirates.
    PLoS One. 2024;19:e0307020.
    >> Share

  439. FRITSCHI N, Gureva T, Eliseev P, Jackson C, et al
    Diagnosis of tuberculosis infection in children with a novel skin test and the traditional tuberculin skin test: An observational study.
    PLoS One. 2024;19:e0293272.
    >> Share

  440. MCKEE S, Halsall T, Sheikhan NY, Knight R, et al
    "Pictures helped me understand it in a way words couldn't": Youth reflections participating in a youth-led photovoice study.
    PLoS One. 2024;19:e0308165.
    >> Share

  441. SHI H, Zhu Y, Shang K, Tian T, et al
    Development of innovative multi-epitope mRNA vaccine against central nervous system tuberculosis using in silico approaches.
    PLoS One. 2024;19:e0307877.
    >> Share

  442. KATZ MA, Rojas Castro MY, Chakhunashvili G, Chitadze N, et al
    Primary series COVID-19 vaccine effectiveness among health care workers in the country of Georgia, March-December 2021.
    PLoS One. 2024;19:e0307805.
    >> Share

  443. NGUYEN K, Relja B, Epperson M, Park SH, et al
    Salivary immune responses after COVID-19 vaccination.
    PLoS One. 2024;19:e0307936.
    >> Share

  444. SHEN J, Ji C, Luo X, Hu Y, et al
    Economic evaluation on meningococcal vaccination strategies among children under nine years of age in Zhejiang province, China.
    PLoS One. 2024;19:e0310274.
    >> Share

  445. SHRESTHA M, Sherer PP, Paek SC, Prasert K, et al
    Influenza vaccine hesitancy among healthcare workers in a Northeastern province in Thailand: Findings of a cross-sectional survey.
    PLoS One. 2024;19:e0310761.
    >> Share

  446. GHOSH S, Banerjee M, Chattopadhyay AK
    Effect of vaccine dose intervals: Considering immunity levels, vaccine efficacy, and strain variants for disease control strategy.
    PLoS One. 2024;19:e0310152.
    >> Share

  447. PARVIN R, Habib Ullah Masum M, Ferdous J, Mahdeen AA, et al
    Designing of a chimeric multiepitope vaccine against bancroftian lymphatic filariasis through immunoinformatics approaches.
    PLoS One. 2024;19:e0310398.
    >> Share

  448. MAHASING C, Suphanchaimat R, Teekasap P, Nittayasoot N, et al
    Cost effectiveness analysis comparing varying booster intervals of vaccination policies to address COVID-19 situation in Thailand, 2023.
    PLoS One. 2024;19:e0310427.
    >> Share

  449. MOGHNIEH R, Haddad W, Jbeily N, El-Hassan S, et al
    Immunogenicity and real-world effectiveness of COVID-19 vaccines in Lebanon: Insights from primary and booster schemes, variants, infections, and hospitalization.
    PLoS One. 2024;19:e0306457.
    >> Share

  450. HASHEMPOUR A, Khodadad N, Bemani P, Ghasemi Y, et al
    Design of multivalent-epitope vaccine models directed toward the world's population against HIV-Gag polyprotein: Reverse vaccinology and immunoinformatics.
    PLoS One. 2024;19:e0306559.
    >> Share

  451. BUNDUR A, Riaz R, Elibol FKE, Demir T, et al
    Effects of spray-dried plasma on performance, carcass parameters, tibia quality and Newcastle disease vaccine efficacy in broiler chicken fed corn-soy diets with two varying levels of digestible amino acids and AMEn density.
    PLoS One. 2024;19:e0309263.
    >> Share

  452. BANICO EC, Sira EMJS, Fajardo LE, Dulay ANG, et al
    Advancing one health vaccination: In silico design and evaluation of a multi-epitope subunit vaccine against Nipah virus for cross-species immunization using immunoinformatics and molecular modeling.
    PLoS One. 2024;19:e0310703.
    >> Share

  453. KIAKUVUE YN, Mall S, Govender N, Gottberg AV, et al
    Demographic and pathogen characteristics of incident bacterial meningitis in infants in South Africa: A cohort study.
    PLoS One. 2024;19:e0310528.
    >> Share

  454. EZEZIKA O, Kotsaftis TS, Marson A
    Upstream factors impacting COVID-19 vaccination rates across Africa: A systematic review protocol.
    PLoS One. 2024;19:e0310884.
    >> Share

  455. LEE MF, Chen YH, Song PP, Lin TM, et al
    Correction: Therapeutic DNA vaccine attenuates itching and allergic inflammation in mice with established biting midge allergy.
    PLoS One. 2024;19:e0311200.
    >> Share

  456. JEON HE, Lee S, Lee J, Roh G, et al
    SARS-CoV2 mRNA vaccine intravenous administration induces myocarditis in chronic inflammation.
    PLoS One. 2024;19:e0311726.
    >> Share

  457. WORKU BT, Wordofa EA, Senbeto G, Zinab B, et al
    Age-appropriate vaccination and associated factors among children aged 12-35 months in Ethiopia: A multi-level analysis.
    PLoS One. 2024;19:e0305801.
    >> Share

  458. MCNEILL-JOHNSON A, Hudson Z, Moore B, Okocha D, et al
    Pandemic perspectives from detained youth during COVID-19: Bridging the knowledge gap for future safeguards.
    PLoS One. 2024;19:e0309179.
    >> Share

  459. BOLIJN R, Spijkerman AMW, Galenkamp H, Blokstra A, et al
    Differences in SARS-CoV-2 antibody prevalence at the end of the pre-vaccination period between age groups: A cross-sectional analysis of the multi-ethnic population-based HELIUS study.
    PLoS One. 2024;19:e0311196.
    >> Share

  460. MWIINDE AM, Kaonga P, Jacobs C, Zulu JM, et al
    Determinants of COVID-19 vaccine acceptance and hesitancy among adolescents and youths aged 10-35 years in sub-Saharan African countries: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0310827.
    >> Share

  461. FLOOD T, McLaughlin DM, Wilson DI, Hughes CM, et al
    An exploration of teacher and school-based nurse perceptions of current HPV education offered to students 15-16 years old in post-primary schools in Northern Ireland, UK.
    PLoS One. 2024;19:e0311651.
    >> Share

  462. BUI DP, Bajema KL, Huang Y, Yan L, et al
    Development of a prediction model for 30-day COVID-19 hospitalization and death in a national cohort of Veterans Health Administration patients-March 2022-April 2023.
    PLoS One. 2024;19:e0307235.
    >> Share

  463. HARTANTI MD, Panjaitan NSD, Sunarno S, Ningrum N, et al
    Seroprevalence of Bordetella pertussis infection in children 1-14 years old: Indonesia basic health research (Riskesdas) 2013 and 2018 data.
    PLoS One. 2024;19:e0311362.
    >> Share

  464. BILGIN GM, Munira SL, Lokuge K, Glass K, et al
    Cost-effectiveness analysis of COVID-19 booster doses and oral antivirals: Case studies in the Indo-Pacific.
    PLoS One. 2024;19:e0294091.
    >> Share

  465. MULLER DL, Stuckey H, Flores ES, Wang L, et al
    Primary care physicians' perspectives on adults with diabetes and the recommended hepatitis B vaccine: A qualitative study.
    PLoS One. 2024;19:e0312168.
    >> Share

  466. ALRABADI N, Obeidat H, Haddad R, Alyassin N, et al
    The value of using COVID-19 antibody tests as a potential approach to prioritize vaccination delivery.
    PLoS One. 2024;19:e0311881.
    >> Share

  467. NAQVI AA, Islam MA, Jahangir A, Rizvi M, et al
    Cross-cultural adaptation and validation of an Urdu version of the Vaccine Attitudes Examination (VAX-U) scale.
    PLoS One. 2024;19:e0312459.
    >> Share

  468. MAAMOR NH, Muhamad NA, Mohd Dali NS, Leman FN, et al
    Prevalence of caregiver hesitancy for vaccinations in children and its associated factors: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0302379.
    >> Share

  469. MAHDEEN AA, Hossain I, Masum MHU, Islam S, et al
    Designing novel multiepitope mRNA vaccine targeting Hendra virus (HeV): An integrative approach utilizing immunoinformatics, reverse vaccinology, and molecular dynamics simulation.
    PLoS One. 2024;19:e0312239.
    >> Share

  470. LEE AA, Skyles TJ, Jensen JL, Ord B, et al
    Effects of religion, politics and distance to providers on HPV vaccine attitudes and intentions of parents in rural Utah.
    PLoS One. 2024;19:e0312549.
    >> Share

  471. LI S, Li W
    Dynamical behaviors of a stochastic SIVS epidemic model with the Ornstein-Uhlenbeck process and vaccination of newborns.
    PLoS One. 2024;19:e0310175.
    >> Share

  472. KIM Y, Lim MK
    The potential role of perceived neighborhood social cohesion on COVID-19 vaccination uptake among individuals aged 50 and older: Results from the Korean Community Health Survey.
    PLoS One. 2024;19:e0312309.
    >> Share

  473. ELSEY JWB, Manheim D, Marsh A, Schmit V, et al
    Ethical acceptability of human challenge trials: Consultation with the US public and with research personnel.
    PLoS One. 2024;19:e0307808.
    >> Share

  474. NEBANGWA DN, Shey RA, Shadrack DM, Shintouo CM, et al
    Predictive immunoinformatics reveal promising safety and anti-onchocerciasis protective immune response profiles to vaccine candidates (Ov-RAL-2 and Ov-103) in anticipation of phase I clinical trials.
    PLoS One. 2024;19:e0312315.
    >> Share

  475. YOUSSEF E, Calvert A, Greening V, Pearce D, et al
    Understanding the barriers and enablers to participation in vaccine trials in a pregnant population from diverse ethnic background in an inner-city UK hospital.
    PLoS One. 2024;19:e0312799.
    >> Share

  476. ZANIB SA, Zubair T, Ramzan S, Riaz MB, et al
    A conformable fractional finite difference method for modified mathematical modeling of SAR-CoV-2 (COVID-19) disease.
    PLoS One. 2024;19:e0307707.
    >> Share

  477. PELZER PT, Holleman M, Helinski MEH, Weinberg AL, et al
    The TB vaccine clinical trial centre directory: An inventory of clinical trial centres in Sub-Saharan Africa.
    PLoS One. 2024;19:e0292981.
    >> Share

  478. ZHU Y, Shi J, Wang Q, Zhu Y, et al
    Novel dual-pathogen multi-epitope mRNA vaccine development for Brucella melitensis and Mycobacterium tuberculosis in silico approach.
    PLoS One. 2024;19:e0309560.
    >> Share

  479. AYAZ H, Celik MH, Koytak HZ, Yanik IE, et al
    Exploring vaccine hesitancy in digital public discourse: From tribal polarization to socio-economic disparities.
    PLoS One. 2024;19:e0308122.
    >> Share

  480. NANTEZA MB, Nanyonjo G, Kyakuwa N, Nakanjako F, et al
    COVID-19 vaccine uptake and associated factors among individuals living in a peri-urban area in Uganda: A cross-sectional study.
    PLoS One. 2024;19:e0312377.
    >> Share

  481. OYEDEJI O, Kintziger KW, Springer CM, Ehrlich S, et al
    Examining HPV vaccination behavior among young adults: Insights from applying the Health Belief Model.
    PLoS One. 2024;19:e0312700.
    >> Share

  482. KUDDUS MA, Mohiuddin M, Paul AK, Rahman A, et al
    Insights from qualitative and bifurcation analysis of COVID-19 vaccination model in Bangladesh.
    PLoS One. 2024;19:e0312780.
    >> Share

  483. KLEGERMAN ME, Peng T, Seferovich I, Rahbar MH, et al
    Absolute concentration estimation of COVID-19 convalescent and post-vaccination IgG antibodies.
    PLoS One. 2024;19:e0311777.
    >> Share

  484. SERETI I, Shaw-Saliba K, Dodd LE, Dewar RL, et al
    Correction: Design of an observational multi-country cohort study to assess immunogenicity of multiple vaccine platforms (InVITE).
    PLoS One. 2024;19:e0314048.
    >> Share

  485. LI Y, Kong D, Ding Y, Wang J, et al
    The potential impact of COVID-19 vaccination on patients with immune thrombocytopenic purpura: A protocol for systematic review and meta-analysis.
    PLoS One. 2024;19:e0308546.
    >> Share

  486. HAWLADER MDH, Eva FN, Khan MAS, Islam T, et al
    Acceptance of Human Papillomavirus (HPV) vaccine among the parents of eligible daughters (9-15 years) in Bangladesh: A nationwide study using Health Belief Model.
    PLoS One. 2024;19:e0310779.
    >> Share

  487. EZEZIKA O, Kotsaftis TS, Amponsah-Dacosta E, Demi S, et al
    A protocol for modeling the factors influencing the deployment of the COVID-19 vaccine across African countries.
    PLoS One. 2024;19:e0311800.
    >> Share

  488. CHEWASKULYONG B, Satjaritanun P, Ketpueak T, Suksombooncharoen T, et al
    Neutralizing antibodies and safety of a COVID-19 vaccine against SARS-CoV-2 wild-type and Omicron variants in solid cancer patients.
    PLoS One. 2024;19:e0310781.
    >> Share

  489. GUPTA MD, Kunal S, M P G, Goyal D, et al
    Correction: Impact of COVID-19 vaccination on mortality after acute myocardial infarction.
    PLoS One. 2024;19:e0314647.
    >> Share

  490. VASUDEVAN L, Porter RM, Campos I, Turner EL, et al
    An ADaptivE PrenaTal (ADEPT) intervention to increase childhood vaccinations: Protocol for a cluster randomized trial and nested mixed methods evaluation.
    PLoS One. 2024;19:e0313742.
    >> Share

  491. DANIELS V, Saxena K, Patterson-Lomba O, Gomez-Lievano A, et al
    Modeling the health and economic implications of adopting a 1-dose 9-valent human papillomavirus vaccination program in adolescents in low/middle-income countries: An analysis of Indonesia.
    PLoS One. 2024;19:e0310591.
    >> Share

  492. HAMDAN O, Amarin JZ, Potter M, Haddadin Z, et al
    Seasonal influenza vaccination: Attitudes and practices of healthcare providers in Jordan.
    PLoS One. 2024;19:e0314224.
    >> Share

  493. SHURO L, Lawrence E, Knight L, Schneider H, et al
    Enhancing childhood immunization coverage in Mozambique and Malawi: Study protocol of a mixed methods evaluation of the 'Let's talk about vaccines' multisite community-based participatory project.
    PLoS One. 2024;19:e0311052.
    >> Share

  494. STREETER AJ, Rodgers LR, Masoli J, Lin NX, et al
    Correction: Real-world effectiveness of pneumococcal vaccination in older adults: Cohort study using the UK Clinical Practice Research Datalink.
    PLoS One. 2024;19:e0314373.
    >> Share

  495. ANNI NS, Rehman N, Nyambi A, Musiwa A, et al
    Knowledge, attitudes, and practices towards Human Papilloma Virus and uptake of HPV vaccine: A protocol for a systematic review.
    PLoS One. 2024;19:e0313887.
    >> Share

  496. JUNGKUNZ S
    Asymmetric polarization by vaccination status identification during the COVID-19 pandemic.
    PLoS One. 2024;19:e0311962.
    >> Share

  497. MARRA F, Yip M, Cragg JJ, Vadlamudi NK, et al
    Systematic review and meta-analysis of recombinant herpes zoster vaccine in immunocompromised populations.
    PLoS One. 2024;19:e0313889.
    >> Share

  498. LAMICHHANE R, Adhikari P, Pathak BD, Rai A, et al
    Knowledge, attitude, and practice towards Hepatitis B and vaccination status of pre-clinical medical students at Sylhet Women's Medical College, Bangladesh.
    PLoS One. 2024;19:e0310443.
    >> Share

  499. SITA L, Caserotti M, Zamparini M, Lotto L, et al
    Impact of COVID-19 vaccination on preventive behavior: The importance of confounder adjustment in observational studies.
    PLoS One. 2024;19:e0313117.
    >> Share

  500. RODRIGUES DA SILVA TP, Moreira CM, Souza JFA, Fernandes EG, et al
    Risk classification for the transmission of vaccine-preventable diseases in the state of Minas Gerais, Brazil: 2018 to 2022.
    PLoS One. 2024;19:e0311932.
    >> Share

  501. HANDAYANI S, Rias YA, Kurniasari MD, Agustin R, et al
    Correction: Relationship of spirituality, health engagement, health belief and attitudes toward acceptance and willingness to pay for a COVID-19 vaccine.
    PLoS One. 2024;19:e0315519.
    >> Share

  502. SANDERS C, Burnett K, Ray L, Ulanova M, et al
    An exploration of the role of trust and rapport in enhancing vaccine uptake among Anishinaabe in rural northern Ontario.
    PLoS One. 2024;19:e0308876.
    >> Share

  503. MOSANYA AU, Ezekwelu A, Ugochukwu EJ, Ukoha-Kalu BO, et al
    Factors associated with post-pandemic acceptance of COVID-19 vaccines among students in three Nigerian universities.
    PLoS One. 2024;19:e0312271.
    >> Share

  504. SIBANDA M, Burnett RJ, Godman B, Meyer JC, et al
    Vaccine uptake, associated factors and reasons for vaccination status among the South African elderly; findings and next steps.
    PLoS One. 2024;19:e0314098.
    >> Share

  505. SARKER A, Rahman MM, Khatun C, Barai C, et al
    In Silico design of a multi-epitope vaccine for Human Parechovirus: Integrating immunoinformatics and computational techniques.
    PLoS One. 2024;19:e0302120.
    >> Share

  506. HURST JR, Naghibosadat M, Budowski P, Liu J, et al
    Comparison of a SARS-CoV-2 mRNA booster immunization containing additional antigens to a spike-based mRNA vaccine against Omicron BA.5 infection in hACE2 mice.
    PLoS One. 2024;19:e0314061.
    >> Share

  507. SANTOSH AK, Kumar D, Kaur C, Gupta P, et al
    Evaluation of the immune status of dogs vaccinated against rabies by an enzyme-linked immunosorbent assay using crude preparations of insect cells infected with a recombinant baculovirus encoding the rabies virus glycoprotein gene.
    PLoS One. 2024;19:e0314516.
    >> Share

  508. EHSASATVATAN M, Baghban Kohnehrouz B
    Designing and immunomolecular analysis of a new broad-spectrum multiepitope vaccine against divergent human papillomavirus types.
    PLoS One. 2024;19:e0311351.
    >> Share

  509. GUERRERIO AL, Mateja A, MacCarrick G, Fintzi J, et al
    Cardiovascular complications in vascular connective tissue disorders after COVID-19 infection and vaccination.
    PLoS One. 2024;19:e0315499.
    >> Share


  510. Correction: Vaccination against misinformation: The inoculation technique reduces the continued influence effect.
    PLoS One. 2024;19:e0316311.
    >> Share

  511. EDOSSA ZK, Erchafo Lubago B, Baye MF, Alemu RK, et al
    Vaccination card loss and associated factors in Ethiopia: A multilevel analysis using Ethiopia Mini Demographic and Health Survey 2019 data.
    PLoS One. 2024;19:e0311925.
    >> Share

  512. BEISSEGULOVA G, Ramazanova B, Mustafina K, Begadilova T, et al
    Prevalence of nasopharyngeal Streptococcus Pneumoniae carriage in infants: A systematic review and meta-analysis of cohort studies and randomized controlled trials.
    PLoS One. 2024;19:e0315461.
    >> Share

  513. ZHENG J, Li B, Jia L, Zhang J, et al
    Tumorigenicity decrease in Bcl-xL deficient MDCK cells ensuring the safety for influenza vaccine production.
    PLoS One. 2024;19:e0311069.
    >> Share

  514. D'SOUZA GC, Yingst JM, Krebs NM, Bordner C, et al
    Using the diffusion of innovations theory to understand factors associated with COVID-19 vaccination among tobacco users.
    PLoS One. 2024;19:e0309780.
    >> Share

  515. NAULLY PG, Tan MI, Nugrahapraja H, Artarini AA, et al
    Design of multi-epitope-based therapeutic vaccine candidates from HBc and HBx proteins of hepatitis B virus using reverse vaccinology and immunoinformatics approaches.
    PLoS One. 2024;19:e0313269.
    >> Share

  516. SABATER-GARRIZ A, Ceron JJ, Montoya P, Riquelme I, et al
    Potential use of salivary TNF-alpha as a vaccine-induced pain biomarker in people with cerebral palsy and communication disorders.
    PLoS One. 2024;19:e0308386.
    >> Share

  517. TARIGAN S, Sekarmila G, Apas, Sumarningsih, et al
    Challenges and strategies in the soluble expression of CTA1-(S14P5)4-DD and CTA1-(S21P2)4-DD fusion proteins as candidates for COVID-19 intranasal vaccines.
    PLoS One. 2024;19:e0306153.
    >> Share

  518. ZHANG Y, Guo X, Su Y
    Spatiotemporal dynamic and regional differences of public attention to vaccination: An empirical study in China.
    PLoS One. 2024;19:e0312488.
    >> Share

  519. BROECKL CV, Hiereth S, Straubinger RK
    A comparative study evaluating three line immunoassays available for serodiagnosis of equine Lyme borreliosis: Detection of Borrelia burgdorferi sensu lato-specific antibodies in serum samples of vaccinated and non-vaccinated horses.
    PLoS One. 2024;19:e0316170.
    >> Share

  520. HOLLISTER J, Porter C, Sprissler R, Beitel SC, et al
    Risk reduction in SARS-CoV-2 infection and reinfection conferred by humoral antibody levels among essential workers during Omicron predominance.
    PLoS One. 2024;19:e0306953.
    >> Share

  521. CHO S, Hisamitsu S, Jin H, Toyoda M, et al
    Analyzing information sharing behaviors during stance formation on COVID-19 vaccination among Japanese Twitter users.
    PLoS One. 2024;19:e0299935.
    >> Share

  522. SAMI MRS, Rani NA, Elahi MME, Hossain MS, et al
    An immunoinformatics and extensive molecular dynamics study to develop a polyvalent multi-epitope vaccine against cryptococcosis.
    PLoS One. 2024;19:e0315105.
    >> Share

  523. CAO Q, Hou Y, Wang C, Yin J, et al
    Effect of human papillomavirus (HPV) vaccination on HPV infection and recurrence of HPV related disease after local surgical treatment: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0312128.
    >> Share

  524. HASSAN MZ, Basher AK, Rahman MZ, Bhuiyan TR, et al
    Study protocol for COVID-19 breakthrough infections and vaccine-induced immune response among a cohort of healthcare workers, Bangladesh.
    PLoS One. 2024;19:e0316121.
    >> Share

  525. AGIMAS MC, Asmamaw M, Hailu MK, Kidie T, et al
    Geospatial mapping to assess the distribution and determinants of zero dose vaccination status hot spots among children in Ethiopia using EDHS 2019: Spatial and geographical weighted regression.
    PLoS One. 2024;19:e0312610.
    >> Share

  526. BHENGU P, Ndwandwe D, Cooper S, Katoto PDMC, et al
    Behavioural and social drivers of human papillomavirus vaccination in eThekwini District of KwaZulu-Natal Province, South Africa.
    PLoS One. 2024;19:e0311509.
    >> Share

  527. DOMNICH A, Trombetta CS, Fallani E, Salvatore M, et al
    Immunogenicity and safety of the MF59-adjuvanted seasonal influenza vaccine in non-elderly adults: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0310677.
    >> Share

  528. NORANATE N, Sripanomphong J, Mphande-Nyasulu FA, Chaorattanakawee S, et al
    Plasmodium falciparum surf4.1 in clinical isolates: From genetic variation and variant diversity to in silico design immunopeptides for vaccine development.
    PLoS One. 2024;19:e0312091.
    >> Share

  529. BELAYACHI J, Obtel M, Mhayi A, Razine R, et al
    Correction: Long term effectiveness of inactivated vaccine BBIBP-CorV (Vero Cells) against COVID-19 associated severe and critical hospitalization in Morocco.
    PLoS One. 2024;19:e0316865.
    >> Share

  530. ABDULLAH M, Ahmad T, Khan A, Kazmi T, et al
    Correction: Community engagement to increase vaccine uptake: Quasi-experimental evidence from Islamabad and Rawalpindi, Pakistan.
    PLoS One. 2024;19:e0316862.
    >> Share

  531. SATO Y, Kawachi I, Saijo Y, Yoshioka E, et al
    Correlates of COVID-19 conspiracy theory beliefs in Japan: A cross-sectional study of 28,175 residents.
    PLoS One. 2024;19:e0310673.
    >> Share

  532. LAARMAN C, Hahne SJ, de Melker HE, Knol MJ, et al
    SARS-CoV-2 risk factors among symptomatic vaccinated adults attending community testing locations in the Netherlands from June 2021 till February 2022.
    PLoS One. 2024;19:e0311229.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016